|
Bibliography |
||
|
(Diagnosis,
Pathogenesis, Vaccines & Drugs) 2054. Akdis CA. Joss A. Akdis M. Blaser K. Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens. [Review] [14 refs] International Archives of Allergy & Immunology. 124(1-3):180-2, 2001 Jan-Mar. 2055. Asero R. Bottazzi G. Nasal polyposis: a study of its association with airborne allergen hypersensitivityy. Annals of Allergy, Asthma, & Immunology. 86(3):283-5, 2001 Mar. 2056. Bengtsson A. Lundberg M. Avila-Carino J. Jacobsson G. Holmgren A. Scheynius A. Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells. Clinical & Experimental Immunology. 123(3):350-60, 2001 Mar. 2057. Choquet-Kastylevsky G. Vial T. Descotes J. Drug allergy diagnosis in humans: possibilities and pitfalls. [Review] [57 refs] Toxicology. 158(1-2):1-10, 2001 Feb 2. 2058. Isolauri E. Sutas Y. Kankaanpaa P. Arvilommi H. Salminen S. Probiotics: effects on immunity. [Review] [56 refs] American Journal of Clinical Nutrition. 73(2 Suppl):444S-450S, 2001 Feb. 2059. Kay AB. Allergy and allergic diseases. Second of two parts. [Review] [95 refs] New England Journal of Medicine. 344(2):109-13, 2001 Jan 11. 2060. Kweon M. Takahashi I. Kiyono H. New insights into mechanism of inflammatory and allergic diseases in mucosal tissues. [Review] [47 refs] Digestion. 63 Suppl 1:1-11, 2001. 2061. Larsen GL. Differences between adult and childhood asthma. [Review] [43 refs] Disease-A-Month. 47(1):34-44, 2001 Jan. 2062. Leff AR. Regulation of leukotrienes in the management of asthma: biology and clinical therapy. [Review] [64 refs] Annual Review of Medicine. 52:1-14, 2001. 2063. Lewis SA. Pavord ID. Stringer JR. Knox AJ. Weiss ST. Britton JR. The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults. Chest. 119(1):105-14, 2001 Jan. 2064. Morton RL. Sheikh S. Corbett ML. Eid NS. Evaluation of the wheezy infant. [Review] [50 refs] Annals of Allergy, Asthma, & Immunology. 86(3):251-6, 2001 Mar. 2065. Nahori MA. Lagranderie M. Lefort J. Thouron F. Joseph D. Winter N. Gicquel B. Lapa e Silva JR. Vargaftig BB. Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns. Vaccine. 19(11-12):1484-95, 2001 Jan 8. 2066. Pichler WJ. Predictive drug allergy testing: an alternative viewpoint. [Review] [40 refs] Toxicology. 158(1-2):31-41, 2001 Feb 2. 2067. Sachs B. Erdmann S. Al-Masaoudi T. Merk HF. In vitro drug allergy detection system incorporating human liver microsomes in chlorazepate-induced skin rash: drug-specific proliferation associated with interleukin-5 secretion. British Journal of Dermatology. 144(2):316-20, 2001 Feb. 2068. Strannegard O. Strannegard IL. The causes of the increasing prevalence of allergy: is atopy a microbial deprivation disorder?. [Review] [103 refs] Allergy. 56(2):91-102, 2001 Feb. 2069. Wever-Hess J. Hermans J. Kouwenberg JM. Duiverman EJ. Wever AM. Hospital admissions and readmissions for asthma in the age group 0-4 years. Pediatric Pulmonology. 31(1):30-6, 2001 Jan.
(Diagnosis, Pathogenesis, Vaccines & Drugs) 2070. Datar RH. Joshi NN. Nucleic acids in diagnosis. [Review] [33 refs] National Medical Journal of India. 14(1):34-42, 2001 Jan-Feb. 2071. Martinez AJ. Visvesvara GS. Balamuthia mandrillaris infection. Journal of Medical Microbiology. 50(3):205-7, 2001 Mar. 2072. Matsuo T. Notohara K. Shiraga F. Yumiyama S. Endogenous amoebic endophthalmitis. Archives of Ophthalmology. 119(1):125-8, 2001 Jan. 2073. Sharma P. Sharma JD. A review of plant species assessed in vitro for antiamoebic activity or both antiamoebic and antiplasmodial properties. [Review] [60 refs] Phytotherapy Research. 15(1):1-17, 2001 Feb. 2074.
Zindrou S. Orozco E.
Linder E. Tellez A. Bjorkman
A. Specific detection of Entamoeba histolytica DNA by hemolysin gene
targeted PCR. Acta Tropica. 78(2):117-25,
2001 Feb 23.
(Diagnosis, Pathogenesis, Vaccines & Drugs) 2075. Crompton DW. Ascaris and ascariasis. [Review] [160 refs] Advances in Parasitology. 48:285-375, 2001. 2076. Jinabhai CC. Taylor M. Coutsoudis A. Coovadia HM. Tomkins AM. Sullivan KR. A health and nutritional profile of rural school children in KwaZulu-Natal, South Africa. Annals of Tropical Paediatrics. 21(1):50-8, 2001 Mar. 2077. Khuroo MS. Hepatobiliary and pancreatic ascariasis. [Review] [20 refs] Indian Journal of Gastroenterology. 20 Suppl 1:C28-32, 2001 Mar. 2078. Tiao MM. Liang CD. Huang SC. Huang CB. Shih HH. Pancreatitis with gallbladder ascariasis in a child: case report. Chang Gung Medical Journal. 24(1):68-71, 2001 Jan. 2079. Valentine CC. Hoffner RJ. Henderson SO. Three common presentations of ascariasis infection in an urban Emergency Department. Journal of Emergency Medicine. 20(2):135-9, 2001 Feb. (Diagnosis, Pathogenesis, Vaccines & Drugs) 2080. Alexis NE. Soukup J. Nierkens S. Becker S. Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma. American Journal of Physiology - Lung Cellular & Molecular Physiology. 280(2):L369-75, 2001 Feb. 2081. Anis AH. Lynd LD. Wang XH. King G. Spinelli JJ. Fitzgerald M. Bai T. Pare P. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ. 164(5):625-31, 2001 Mar 6. 2082. Bartlett SJ. Kolodner K. Butz AM. Eggleston P. Malveaux FJ. Rand CS. Maternal depressive symptoms and emergency department use among inner-city children with asthma. Archives of Pediatrics & Adolescent Medicine. 155(3):347-53, 2001 Mar. 2083. Brook I. Frazier EH. Correlation between microbiology and previous sinus surgery in patients with chronic maxillary sinusitis. Annals of Otology, Rhinology & Laryngology. 110(2):148-51, 2001 Feb. 2084. Crystal RG. Research opportunities and advances in lung disease. JAMA. 285(5):612-8, 2001 Feb 7. 2085. Gani F. Pozzi E. Crivellaro MA. Senna G. Landi M. Lombardi C. Canonica GW. Passalacqua G. The role of patient training in the management of seasonal rhinitis and asthma: clinical implications. Allergy. 56(1):65-8, 2001 Jan. 2086. Gavett SH. Koren HS. The role of particulate matter in exacerbation of atopic asthma. International Archives of Allergy & Immunology. 124(1-3):109-12, 2001 Jan-Mar. 2087. Grennan DM. Gray J. Loudon J. Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Annals of the Rheumatic Diseases. 60(3):214-7, 2001 Mar. 2088. Hallsworth MP. Twort CH. Lee TH. Hirst SJ. beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells. British Journal of Pharmacology. 132(3):729-41, 2001 Feb. 2089. Holgate ST. Lackie PM. Howarth PH. Roche WR. Puddicombe SM. Richter A. Wilson SJ. Holloway JW. Davies DE. Invited lecture: activation of the epithelial mesenchymal trophic unit in the pathogenesis of asthma. International Archives of Allergy & Immunology. 124(1-3):253-8, 2001 Jan-Mar. 2090. Horne R. Mailey E. Frost S. Lea R. Shared care: a qualitative study of GPs' and hospital doctors' views on prescribing specialist medicines. British Journal of General Practice. 51(464):187-93, 2001 Mar. 2080. Hoshino M. Takahashi M. Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. Journal of Allergy & Clinical Immunology. 107(2):295-301, 2001 Feb. 2081. Johnston SL. Openshaw PJ. The protective effect of childhood infections. [letter; comment]. BMJ. 322(7283):376-7, 2001 Feb 17. 2082. Jones AH. Allopathic medicine gone awry. Journal of the American Osteopathic Association. 101(1):20, 2001 Jan. 2083. Kanazawa S. Tsunoda T. Onuma E. Majima T. Kagiyama M. Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. American Journal of Gastroenterology. 96(3):822-8, 2001 Mar. 2084. Kotaru C. Coreno A. Skowronski M. Ciufo R. McFadden ER Jr. Exhaled nitric oxide and thermally induced asthma. American Journal of Respiratory & Critical Care Medicine. 163(2):383-8, 2001 Feb. 2085. Kuo ML. Huang JL. Yeh KW. Li PS. Hsieh KH. Evaluation of Th1/Th2 ratio and cytokine production profile during acute exacerbation and convalescence in asthmatic children. Annals of Allergy, Asthma, & Immunology. 86(3):272-6, 2001 Mar. 2086. Larsen GL. Differences between adult and childhood asthma. [Review] [43 refs] Disease-A-Month. 47(1):34-44, 2001 Jan. 2087. Lazzeri N. Belvisi MG. Patel HJ. Yacoub MH. Fan Chung K. Mitchell JA. Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy. American Journal of Respiratory Cell & Molecular Biology. 24(1):44-48, 2001 Jan. 2088. Leff AR. Regulation of leukotrienes in the management of asthma: biology and clinical therapy. [Review] [64 refs] Annual Review of Medicine. 52:1-14, 2001. 2089. Lenney W. RSV disease--is there a role for prevention?. Respiratory Medicine. 95(3):170-2, 2001 Mar. 2090. Lewis SA. Pavord ID. Stringer JR. Knox AJ. Weiss ST. Britton JR. The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults. Chest. 119(1):105-14, 2001 Jan. 2091. Marks F. Harrell K. Fischer R. Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma. Southern Medical Journal. 94(2):256-7, 2001 Feb. 2092. Nahori MA. Lagranderie M. Lefort J. Thouron F. Joseph D. Winter N. Gicquel B. Lapa e Silva JR. Vargaftig BB. Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns. Vaccine. 19(11-12):1484-95, 2001 Jan 8. 2093. Nell H. Louw CM. Cyster H. Williams Z. Bardin PG. Joubert JR. Therapeutic equivalence study of two formulations (innovator v. generic) of beclomethasone dipropionate in adult asthmatic patients. South African Medical Journal. 91(1):51-6, 2001 Jan. 2094. Nicosia S. Capra V. Rovati GE. Leukotrienes as mediators of asthma. [Review] [210 refs] Pulmonary Pharmacology & Therapeutics. 14(1):3-19, 2001. 2095. Obase Y. Shimoda T. Mitsuta K. Matsuo N. Matsuse H. Kohno S. Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum. Annals of Allergy, Asthma, & Immunology. 86(3):304-10, 2001 Mar. 2096. Oettgen HC. Geha RS. IgE regulation and roles in asthma pathogenesis. [Review] [155 refs] Journal of Allergy & Clinical Immunology. 107(3):429-40, 2001 Mar. 2097. Powell WS. Ahmed S. Gravel S. Rokach J. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis. Journal of Allergy & Clinical Immunology. 107(2):272-8, 2001 Feb. 2098. Roland M. Bhowmik A. Sapsford RJ. Seemungal TA. Jeffries DJ. Warner TD. Wedzicha JA. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax. 56(1):30-5, 2001 Jan. 2099. Stellato C. Brummet ME. Plitt JR. Shahabuddin S. Baroody FM. Liu MC. Ponath PD. Beck LA. Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells. Journal of Immunology. 166(3):1457-61, 2001 Feb 1. 2100. Tanaka H. Miyazaki N. Oashi K. Teramoto S. Shiratori M. Hashimoto M. Ohmichi M. Abe S. IL-18 might reflect disease activity in mild and moderate asthma exacerbation. Journal of Allergy & Clinical Immunology. 107(2):331-6, 2001 Feb. 2101. Tang RB. Chen SJ. Soluble interleukin-2 receptor and interleukin-4 in sera of asthmatic children before and after a prednisolone course. Annals of Allergy, Asthma, & Immunology. 86(3):314-7, 2001 Mar. 2102. Tashkin DP. Airway effects of marijuana, cocaine, and other inhaled illicit agents. [Review] [139 refs] Current Opinion in Pulmonary Medicine. 7(2):43-61, 2001 Mar. 2103. Tonnel AB. Gosset P. Tillie-Leblond I. Characteristics of the Inflammatory response in bronchial lavage fluids from patients with status asthmaticus. International Archives of Allergy & Immunology. 124(1-3):267-71, 2001 Jan-Mar. 2104. Wickens K. Crane J. Kemp T. Lewis S. D'Souza W. Sawyer G. Stone L. Tohill S. Kennedy J. Slater T. Rains N. Pearce N. A case-control study of risk factors for asthma in New Zealand children. Australian & New Zealand Journal of Public Health. 25(1):44-9, 2001. (Diagnosis, Pathogenesis, Vaccines & Drugs) 2116. Anonymous. From the Centers for Disease Control and Prevention. Underdiagnosis of dengue--Laredo, Texas, 1999. JAMA. 285(7):877,2001 Feb 21. 2117. Beasley DW. Aaskov JG. Epitopes on the dengue 1 virus envelope protein recognized by neutralizing igm monoclonal antibodies. Virology. 279(2):447-58, 2001 Jan 20. 2118. Bethell DB. Gamble J. Pham PL. Nguyen MD. Tran TH. Ha TH. Tran TN. Dong TH. Gartside IB. White NJ. Day NP. Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clinical Infectious Diseases. 32(2):243-53, 2001 Jan 15. 2119. Carbajo AE. Schweigmann N. Curto SI. de Garin A. Bejaran R. Dengue transmission risk maps of Argentina. Tropical Medicine & International Health. 6(3):170-83, 2001 Mar. 2120. Fouque F. Vazeille M. Mousson L. Gaborit P. Carinci R. Issaly J. Rodhain F. Failloux AB. Aedes aegypti in French Guiana: susceptibility to a dengue virus. Tropical Medicine & International Health. 6(1):76-82, 2001 Jan. 2121. Ho LJ. Wang JJ. Shaio MF. Kao CL. Chang DM. Han SW. Lai JH. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production Journal of Immunology. 166(3):1499-506, 2001 Feb 1. 2122. Lin CF. Lei HY. Liu CC. Liu HS. Yeh TM. Wang ST. Yang TI. Sheu FC. Kuo CF. Lin YS. Generation of IgM anti-platelet autoantibody in dengue patients. Journal of Medical Virology. 63(2):143-9, 2001 Feb. 2123. Nawa M. Takasaki T. Yamada KI. Akatsuka T. Kurane I. Development of dengue IgM-capture enzyme-linked immunosorbent assay with higher sensitivity using monoclonal detection antibody. Journal of Virological Methods. 92(1):65-70, 2001 Mar. 2124. Ooi EE. Hart TJ. Tan HC. Chan SH. Dengue seroepidemiology in Singapore. Lancet. 357(9257):685-6, 2001 Mar 3. 2125. Shurtleff AC. Beasley DW. Chen JJ. Ni H. Suderman MT. Wang H. Xu R. Wang E. Weaver SC. Watts DM. Russell KL. Barrett AD. Genetic variation in the 3' non-coding region of dengue viruses. Virology. 281(1):75-87, 2001 Mar 1. 2126. Sriburi R. Keelapang P. Duangchinda T. Pruksakorn S. Maneekarn N. Malasit P. Sittisombut N. Construction of infectious dengue 2 virus cDNA clones using high copy number plasmid. Journal of Virological Methods. 92(1):71-82, 2001 Mar. 2127. Sudiro TM. Zivny J. Ishiko H. Green S. Vaughn DW. Kalayanarooj S. Nisalak A. Norman JE. Ennis FA. Rothman AL. Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. Journal of Medical Virology. 63(1):29-34, 2001 Jan. 2128. Yang KD. Yeh WT. Yang MY. Chen RF. Shaio MF. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. Journal of Medical Virology. 63(2):150-7, 2001 Feb. (Diagnosis, Pathogenesis, Vaccines & Drugs) 2129. Abdelgabar A. Owen A. Starczewski A. Subashchandran R. A case of voluminous diarrhoea with hypokalaemic acidosis. International Journal of Clinical Practice. 55(1):64-5, 2001 Jan-Feb. 2130. Armah GE. Pager CT. Asmah RH. Anto FR. Oduro AR. Binka F. Steele D. Prevalence of unusual human rotavirus strains in Ghanaian children. Journal of Medical Virology. 63(1):67-71, 2001 Jan. 2131. Balbir-Gurman A. Schapira D. Nahir M. Arthritis related to ileal pouchitis following total proctocolectomy for ulcerative colitis. Seminars in Arthritis & Rheumatism. 30(4):242-8, 2001 Feb. 2132. Barrachina MD. Panes J. Esplugues JV. Role of nitric oxide in gastrointestinal inflammatory and ulcerative diseases: perspective for drugs development. [Review] [132 refs] Current Pharmaceutical Design. 7(1):31-48, 2001 Jan. 2133. Behari J. Stagon L. Calderwood SB. pepA, a gene mediating pH regulation of virulence genes in Vibrio cholerae. Journal of Bacteriology. 183(1):178-88, 2001 Jan. 2134. Boulay F. Berthier F. Dahan C. Benchimol D. Seasonal variation in acute intestinal vasculopathy mortality in France. American Journal of Gastroenterology. 96(3):812-7, 2001 Mar. 2135. Brigden ML. Detection, education and management of the asplenic or hyposplenic patient. [see comments]. [Review] [23 refs] American Family Physician. 63(3):499-506, 508, 2001 Feb 1. 2136. Brown EW. LeClerc JE. Li B. Payne WL. Cebula TA. Phylogenetic evidence for horizontal transfer of mutS alleles among naturally occurring Escherichia coli strains. Journal of Bacteriology. 183(5):1631-44, 2001 Mar. 2137. Buchner AM. Sonnenberg A. Medical diagnoses and procedures associated with clostridium difficile colitis. American Journal of Gastroenterology. 96(3):766-72, 2001 Mar. 2138. Bytzer P. Talley NJ. Jones MP. Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Alimentary Pharmacology & Therapeutics. 15(1):137-42, 2001 Jan. 2139. Cezard JP. Duhamel JF. Meyer M. Pharaon I. Bellaiche M. Maurage C. Ginies JL. Vaillant JM. Girardet JP. Lamireau T. Poujol A. Morali A. Sarles J. Olives JP. Whately-Smith C. Audrain S. Lecomte JM. Efficacy and tolerability of racecadotril in acute diarrhea in children. Gastroenterology. 120(4):799-805, 2001 Mar. 2129. Donnenberg MS. Whittam TS. Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coli. [Review] [46 refs] Journal of Clinical Investigation. 107(5):539-48, 2001 Mar. 2130. Feng P. Weagant SD. Monday SR. Genetic analysis for virulence factors in Escherichia coli O104:H21 that was implicated in an outbreak of hemorrhagic colitis. Journal of Clinical Microbiology. 39(1):24-8, 2001 Jan. 2131. Gilbert P. Self S. Rao M. Naficy A. Clemens J. Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation. [Review] [65 refs] Journal of Clinical Epidemiology. 54(1):68-85, 2001 Jan. 2132. Hickner JM. Bartlett JG. Besser RE. Gonzales R. Hoffman JR. Sande MA. American Academy of Family Physicians. American College of Physicians-American Society of Internal Mediciine. Centers for Disease Control. Infectious Diseases Society of America. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Annals of Internal Medicine. 134(6):498-505, 2001 Mar 20. 2133. Johnson JR. Delavari P. Stell AL. Whittam TS. Carlino U. Russo TA. Molecular comparison of extraintestinal Escherichia coli isolates of the same electrophoretic lineages from humans and domestic animals. Journal of Infectious Diseases. 183(1):154-9, 2001 Jan 1. 2134. Kennea N. Norbury R. Anderson G. Tekay A. Congenital microvillous inclusion disease presenting as antenatal bowel obstruction. Ultrasound in Obstetrics & Gynecology. 17(2):172-4, 2001 Feb. 2135. Kirkpatrick ID. Greenberg HM. Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy?. AJR. American Journal of Roentgenology. 176(3):635-9, 2001 Mar. 2136. Kweon M. Takahashi I. Kiyono H. New insights into mechanism of inflammatory and allergic diseases in mucosal tissues. [Review] [47 refs] Digestion. 63 Suppl 1:1-11, 2001. 2137. Miki H. Kobayashi S. Harada H. Yamanoi Y. Uraoka T. Sotozono M. Ohmori M. Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication. Journal of Gastroenterology. 36(2):121-4, 2001 Feb. 2138. Mylonakis E. Ryan ET. Calderwood SB. Clostridium difficile--Associated diarrhea: A review. [Review] [107 refs] Archives of Internal Medicine. 161(4):525-33, 2001 Feb 26. 2139. Nishimura M. Yamamoto T. Iijima H. Moriwaki Y. Takahashi S. Hada T. Basedow's disease and chronic ulcerative colitis: a case report and review of the Japanese literature. [Review] [24 refs] Internal Medicine. 40(1):44-7, 2001 Jan. 2140. Peeters M. Joossens S. Vermeire S. Vlietinck R. Bossuyt X. Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. American Journal of Gastroenterology. 96(3):730-4, 2001 Mar. 2141. Rodriguez BL. Rojas A. Campos J. Ledon T. Valle E. Toledo W. Fando R. Differential interleukin-8 response of intestinal epithelial cell line to reactogenic and nonreactogenic candidate vaccine strains of Vibrio cholerae. Infection & Immunity. 69(1):613-6, 2001 Jan. 2142. Rudolph I. Goldstein F. DiMarino AJ Jr. Crohn's disease of the esophagus: Three cases and a literature review. [Review] [47 refs] Canadian Journal of Gastroenterology. 15(2):117-22, 2001 Feb. 2143. Shen B. Soffer E. The challenge of irritable bowel syndrome: creating an alliance between patient and physician. [Review] [37 refs] Cleveland Clinic Journal of Medicine. 68(3):224-5, 229-33, 236-7, 2001 Mar. 2144. Vastag B. New vaccine decreases rate of nosocomial infections. JAMA. 285(12):1565-6, 2001 Mar 28. 2145. Wall LL. You're the flight surgeon. 29-yr-old pilot, accompanied by his wife and 6-yr-old boy, each ill with nausea, abdominal cramping and watery diarrhea. Aviation Space & Environmental Medicine. 72(2):146-7, 2001 Feb. (Diagnosis, Pathogenesis, Vaccines & Drugs) 2157. Akiba T. Osaka K. Tang S. Nakayama M. Yamamoto A. Kurane I. Okabe N. Umenai T. Analysis of Japanese encephalitis epidemic in Western Nepal in 1997. Epidemiology & Infection. 126(1): 81-8, 2001 Feb. 2158. Barnett M. Prosser J. Sutton I. Halmagyi GM. Davies L. Harper C. Dalmau J. Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody. Journal of Neurology, Neurosurgery & Psychiatry. 70(2): 222-5, 2001 Feb. 2159. Bash S. Hathout GM. Cohen S. Mesiotemporal T2-weighted hyperintensity: neurosyphilis mimicking herpes encephalitis. Ajnr: American Journal of Neuroradiology. 22(2):314-6, 2001 Feb. 2160. Bradley M. Horton J. Assessing the risk of benzimidazole therapy during pregnancy. Transactions of the Royal Society of Tropical Medicine & Hygiene. 95(1):72-3, 2001 Jan-Feb. 2161. Fine A. Layton M. Lessons from the West Nile viral encephalitis outbreak in New York City, 1999: implications for bioterrorism preparedness. [Review] [5 refs] Clinical Infectious Diseases. 32(2):277-82, 2001 Jan 15. 2162. Iadecola C. Alexander M. Cerebral ischemia and inflammation. [Review] [59 refs] Current Opinion in Neurology. 14(1):89-94, 2001 Feb. 2163. Kassubek J. Juengling FD. Nitzsche EU. Lucking CH. Limbic encephalitis investigated by 18FDG-PET and 3D MRI. Journal of Neuroimaging. 11(1):55-9, 2001 Jan. 2164. Kesson AM. Management of neonatal herpes simplex virus infection. [Review] [30 refs] Paediatric Drugs. 3(2):81-90, 2001. 2165. Konishi E. Fujii A. Mason PW. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. Journal of Virology. 75(5):2204-12, 2001 Mar. 2166. Limoges J. Poluektova L. Ratanasuwan W. Rasmussen J. Zelivyanskaya M. McClernon DR. Lanier ER. Gendelman HE. Persidsky Y. The efficacy of potent anti-retroviral drug combinations tested in a murine model of HIV-1 encephalitis. Virology. 281(1):21-34, 2001 Mar 1. 2167. Lin WR. Wozniak MA. Esiri MM. Klenerman P. Itzhaki RF. Herpes simplex encephalitis: involvement of apolipoprotein E genotype. Journal of Neurology, Neurosurgery & Psychiatry. 70(1):117-9, 2001 Jan. 2168. Marx F. Gritsun TS. Grubeck-Loebenstein B. Gould EA. Diagnostic immunoassays for tick-borne encephalitis virus based on recombinant baculovirus protein expression. Journal of Virological Methods. 91(1):75-84, 2001 Jan. 2169. Muench J. Verdieck A. Lopez-Vasquez A. Newell M. Crossing diagnostic borders: herpes encephalitis complicated by cultural and language barriers. Journal of the American Board of Family Practice. 14(1):46-50, 2001 Jan-Feb. 2170. Odaka M. Yuki N. Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. Journal of Neurology, Neurosurgery & Psychiatry. 70(1):50-5, 2001 Jan. 2171. Onapa AW. Simonsen PE. Pedersen EM. Non-filarial elephantiasis in the Mt. Elgon area (Kapchorwa District) of Uganda. Acta Tropica. 78(2):171-6, 2001 Feb 23. 2172. Pui MH. Memon WA. Magnetic resonance imaging findings in tuberculous meningoencephalitis. Canadian Association of Radiologists Journal. 52(1):43-9, 2001 Feb. 2173. Shu PY. Chen LK. Chang SF. Yueh YY. Chow L. Chien LJ. Chin C. Lin TH. Huang JH. Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination. Vaccine. 19(13-14):1753-63, 2001 Feb 8. (Diagnosis,
Pathogenesis, Vaccines & Drugs) 2174. Esterre P. Plichart C. Sechan Y. Nguyen NL. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Tropical Medicine & International Health. 6(3):190-5, 2001 Mar. 2175. Freedman DO. Plier DA. De Almeida AB. De Oliveira AL. Miranda J. Braga C. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis. Tropical Medicine & International Health. 6(1):37-41, 2001 Jan. 2176. Gyapong M. Gyapong JO. Owusu-Banahene G. Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana. Annals of Tropical Medicine & Parasitology. 95(1):77-86, 2001 Jan. 2177. Jain S. Sodhani P. Gupta S. Sakhuja P. Kumar N. Cytomorphology of filariasis revisited. Expansion of the morphologic spectrum and coexistence with other lesions. Acta Cytologica. 45(2):186-91, 2001 Mar-Apr. (Diagnosis, Pathogenesis, Vaccines & Drugs) 2178. Anonymous. From the Centers for Disease Control and Prevention. Foodborne outbreak of group A rotavirus gastroenteritis among college students--District of Columbia, March-April 2000. JAMA. 285(4):405-6, 2001 Jan 24-31. 2179. Barrachina MD. Panes J. Esplugues JV. Role of nitric oxide in gastrointestinal inflammatory and ulcerative diseases: perspective for drugs development. [Review] [132 refs] Current Pharmaceutical Design. 7(1):31-48, 2001 Jan. 2180. Dingle KE. Colles FM. Wareing DR. Ure R. Fox AJ. Bolton FE. Bootsma HJ. Willems RJ. Urwin R. Maiden MC. Multilocus sequence typing system for Campylobacter jejuni. Journal of Clinical Microbiology. 39(1):14-23, 2001 Jan. 2181. Hassoun HT. Kone BC. Mercer DW. Moody FG. Weisbrodt NW. Moore FA. Post-injury multiple organ failure: the role of the gut. [Review] [122 refs] Shock. 15(1):1-10, 2001 Jan. 2182. Hohmann EL. Nontyphoidal salmonellosis. [Review] [28 refs] Clinical Infectious Diseases. 32(2):263-9, 2001 Jan 15. 2183. Kalabalikis P. Hatzis T. Papadatos J. Gionis D. Danou F. Vlachos P. Paraquat poisoning in a family. Veterinary & Human Toxicology. 43(1):31-3, 2001 Feb. 2184. Kamalaratnam CN. Kang G. Kirubakaran C. Rajan DP. Daniel DJ. Mathan MM. Mathan VI. A prospective study of nosocomial enteric pathogen acquisition in hospitalized children in South India. Journal of Tropical Pediatrics. 47(1):46-9, 2001 Feb. 2185. Kuzuya M. Fujii R. Hamano M. Ohata R. Ogura H. Yamada M. Seroepidemiology of human group C rotavirus in Japan based on a blocking enzyme-linked immunosorbent assay. Clinical & Diagnostic Laboratory Immunology. 8(1):161-5, 2001 Jan. 2186. Marteau PR. de Vrese M. Cellier CJ. Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. [Review] [92 refs] American Journal of Clinical Nutrition. 73(2 Suppl):430S-436S, 2001 Feb. Sethi D. Cumberland P. Hudson MJ. Rodrigues LC. Wheeler JG. Roberts JA. Tompkins DS. Cowden JM. Roderick PJ. A study of infectious intestinal2178. disease in England: risk factors associated with group A rotavirus in children. Epidemiology & Infection. 126(1):63-70, 2001 Feb. 2179. Shetty A. Mendall M. Diagnosing gastroenteritis and travellers' diarrhoea. [Review] [5 refs] Practitioner. 245(1620):192-4, 199-200, 204, 2001 Mar. (Diagnosis, Pathogenesis, Vaccines & Drugs) 2189. Bilezikci B. Haberal AN. Demirhan B. Hepatocyte growth factor in patients with three different stages of chronic liver disease including hepatocellular carcinoma, cirrhosis and chronic hepatitis: an immunohistochemical study. Canadian Journal of Gastroenterology. 15(3):159-65, 2001 Mar. 2190. Chan AY. Dieckhaus KD. Ramsey WH. Cytomegalovirus hepatitis in a nontransplant patient with autoimmune hepatitis taking immunosuppressants. American Journal of Gastroenterology. 96(1):262-3, 2001 Jan. 2191. High KA. Gene transfer as an approach to treating hemophilia. [Review] [70 refs] Circulation Research. 88(2):137-44, 2001 Feb 2. 2192. Kato Y. Nakata K. Omagari K. Kusumoto Y. Mori I. Furukawa R. Tanioka H. Tajima H. Yano M. Eguchi K. Clinical features of fulminant hepatitis in Nagasaki Prefecture, Japan. Internal Medicine. 40(1):5-8, 2001 Jan. 2193. Malik AH. Collins RH Jr. Saboorian MH. Lee WM. Chronic graft-versus-host disease after hematopoietic cell transplantation presenting as an acute hepatitis. American Journal of Gastroenterology. 96(2):588-90, 2001 Feb. 2194. Neubauer K. Saile B. Ramadori G. Liver fibrosis and altered matrix synthesis. [Review] [75 refs] Canadian Journal of Gastroenterology. 15(3):187-93, 2001 Mar. 2195. Sanyal A. Nonalcoholic steatohepatitis. [Review] [79 refs] Indian Journal of Gastroenterology. 20 Suppl 1:C64-70, 2001 Mar. 2196. Senyuz OF. Yesildag E. Emir H. Tekant G. Bozkurt P. Sarimurat N. Soylet Y. Diagnostic laparoscopy in prolonged jaundice. Journal of Pediatric Surgery. 36(3):463-5, 2001 Mar. 2197. Yoon SN. Yoo BM. Hwang KH. Hepatobiliary scintigraphy showing acute complete common bile duct obstruction in a patient with acute hepatitis. Clinical Nuclear Medicine. 26(2):151-2, 2001 Feb. 2198.
Zen Y. Katayanagi K.
Tsuneyama K. Harada K. Araki
I. Nakanuma Y.
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
Pathology International. 51(2):127-31,
2001 Feb. Leishmaniasis
(Diagnosis, Pathogenesis, Vaccines & Drugs) 2199. Attar ZJ. Chance ML. el-Safi S. Carney J. Azazy A. El-Hadi M. Dourado C. Hommel M. Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Tropica. 78(1):11-6, 2001 Jan 15. 2200. Babaloo Z. Kaye PM. Eslami MB. Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines. Transactions of the Royal Society of Tropical Medicine & Hygiene. 95(1):85-8, 2001 Jan-Feb. 2201. Baddini-Caramelli C. Matayoshi S. Moura EM. Araf D. Santo R. Voegels R. Kara-Jose N. Chronic dacryocystitis in American mucocutaneous leishmaniasis. Ophthalmic Plastic & Reconstructive Surgery. 17(1):48-52, 2001 Jan. 2202. Bogdan C. Schonian G. Banuls AL. Hide M. Pratlong F. Lorenz E. Rollinghoff M. Mertens R. Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature. [Review] [35 refs] Clinical Infectious Diseases. 32(2):302-6, 2001 Jan 15. 2203. Bourreau E. Prevot G. Pradinaud R. Launois P. Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12. Journal of Infectious Diseases. 183(6):953-9, 2001 Mar 15. 2204. Buchovsky AS. Campetella O. Russomando G. Franco L. Oddone R. Candia N. Luquetti A. Gonzalez Cappa SM. Leguizamon MS. trans-sialidase inhibition assay, a highly sensitive and specific diagnostic test for Chagas' disease. Clinical & Diagnostic Laboratory Immunology. 8(1):187-9, 2001 Jan. 2205. Carrio J. Riera C. Gallego M. Ribera E. Portus M. In vitro susceptibility of Leishmania infantum to meglumine antimoniate in isolates from repeated leishmaniasis episodes in HIV-coinfected patients. Journal of Antimicrobial Chemotherapy. 47(1):120-1, 2001 Jan. 2206. Fargnoli MC. Peris K. Cerroni L. Piccolo D. Chimenti S. A nodule on the forearm of a patient with Hodgkin disease. Archives of Dermatology. 137(1):85-90, 2001 Jan. 2207. Gicheru MM. Olobo JO. Anjili CO. Orago AS. Modabber F. Scott P. Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection. Infection & Immunity. 69(1):245-51, 2001 Jan. 2208. Hussein MM. Mooij JM. Roujouleh HM. Hamour OA. Felemban H. Non-typhoid Salmonella septicemia and visceral leishmaniasis in a renal transplant patient. Transplantation. 71(3):479-81, 2001 Feb 15. 2209. Kumar A. Mittal M. Prasad S. Treatment of leishmaniasis in pregnancy. International Journal of Gynaecology & Obstetrics. 72(2):189-90, 2001 Feb. 2210. Lachaud L. Chabbert E. Dubessay P. Reynes J. Lamothe J. Bastien P. Comparison of various sample preparation methods for PCR diagnosis of visceral leishmaniasis using peripheral blood. Journal of Clinical Microbiology. 39(2):613-7, 2001 Feb. 2211. Marom D. Offer I. Tamary H. Jaffe CL. Garty BZ. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis. Pediatric Hematology & Oncology. 18(1):65-70, 2001 Jan-Feb. 2212. Pintado V. Martin-Rabadan P. Rivera ML. Moreno S. Bouza E. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine. 80(1):54-73, 2001 Jan. 2213. Pizzuto M. Piazza M. Senese D. Scalamogna C. Calattini S. Corsico L. Persico T. Adriani B. Magni C. Guaraldi G. Gaiera G. Ludovisi A. Gramiccia M. Galli M. Moroni M. Corbellino M. Antinori S. Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. Journal of Clinical Microbiology. 39(1):357-61, 2001 Jan. 2214. Probst P. Stromberg E. Ghalib HW. Mozel M. Badaro R. Reed SG. Webb JR. Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. Journal of Immunology. 166(1):498-505, 2001 Jan 1. 2215. Reinecke P. Gabbart HE. Strunk W. Losche CC. Ocular scleromalacia caused by leishmaniasis: a rare cause of scleral perforation. British Journal of Ophthalmology. 85(2):240-1, 2001 Feb. 2216. Singh RK. Post Kala-azar dermal leishmaniasis. Journal of the Association of Physicians of India. 49:352, 2001 Mar. 2217. Soares NM. Santiago MB. Pontes deCarvalho LC. An improved anti-C3/IgG ELISA for quantification of soluble immune complexes. Journal of Immunological Methods. 249(1-2):199-205, 2001 Mar 1. 2218. Streit JA. Recker TJ. Filho FG. Beverley SM. Wilson ME. Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms. Journal of Immunology. 166(3):1921-9, 2001 Feb 1. 2219. Thakur CP. A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents. 17(1):67-70, 2001 Jan. 2220. Thakur CP. Ahmed S. Observations on amphotericin B treatment of kala-azar given in a rural set up in Bihar, India. Indian Journal of Medical Research. 113:14-8, 2001 Jan.
(Diagnosis, Pathogenesis, Vaccines & Drugs) 2221. Cho SN. Cellona RV. Villahermosa LG. Fajardo TT Jr. Balagon MV. Abalos RM. Tan EV. Walsh GP. Kim JD. Brennan PJ. Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy. Clinical & Diagnostic Laboratory Immunology. 8(1):138-42, 2001 Jan. 2222. Donoghue HD. Holton J. Spigelman M. PCR primers that can detect low levels of Mycobacterium leprae DNA. Journal of Medical Microbiology. 50(2):177-82, 2001 Feb. 2223. John TJ. Muliyil J. Care after cure in leprosy. Lancet. 357(9252):313, 2001 Jan 27. 2224. Kalantri SP. Dr K. V. Desikan gets the Damien-Dutton Award. National Medical Journal of India. 14(1):61, 2001 Jan-Feb. 2225. Kim SK. Dohlman CH. Causes of enlarged corneal nerves. [Review] [81 refs] International Ophthalmology Clinics. 41(1):13-23, 2001 Winter. 2226. Marques MA. Ant nio VL. Sarno EN. Brennan PJ. Pessolani MC. Binding of alpha2-laminins by pathogenic and non-pathogenic mycobacteria and adherence to Schwann cells. Journal of Medical Microbiology. 50(1):23-8, 2001 Jan. 2227. Moraes MO. Sampaio EP. Nery JA. Saraiva BC. Alvarenga FB. Sarno EN. Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient. British Journal of Dermatology. 144(1):175-81, 2001 Jan. 2228. Mvogo CE. Bella-Hiag AL. Ellong A. Achu JH. Nkeng PF. Ocular complications of leprosy in Cameroon. Acta Ophthalmologica Scandinavica. 79(1):31-3, 2001 Feb. 2229. Nunez-Gussman J. Hwang L. Hsu S. Guess what! Targetoid erythematous plaques: an unusual morphological presentation of multibacillary Hansen's disease. European Journal of Dermatology. 11(1):65-7, 2001 Jan-Feb. 2230. Ochoa MT. Stenger S. Sieling PA. Thoma-Uszynski S. Sabet S. Cho S. Krensky AM. Rollinghoff M. Nunes Sarno E. Burdick AE. Rea TH. Modlin RL. T-cell release of granulysin contributes to host defense in leprosy. Nature Medicine. 7(2):174-9, 2001 Feb. 2231. Rambukkana A. Molecular basis for the peripheral nerve predilection of Mycobacterium leprae. [Review] [50 refs] Current Opinion in Microbiology. 4(1):21-7, 2001 Feb. 2232. Salvadori M. Index of suspicion. Case 2. Diagnosis: Leprosy. Pediatrics in Review. 22(1):22-31, 2001 Jan. 2233. Santos DO. Santos SL. Esquenazi D. Nery JA. Defruyt M. Lorre K. Van Heuverswyn H. Evaluation of B7-1 (CD80) and B7-2 (CD86) costimulatory molecules and dendritic cells on the immune response in leprosy. Nihon Hansenbyo Gakkai Zasshi. Japanese Journal of Leprosy. 70(1):15-24, 2001 Feb. 2234. Stockel S. Meurer M. Wozel G. Dapsone-induced photodermatitis in a patient with linear IgA dermatosis. [Review] [17 refs] European Journal of Dermatology. 11(1):50-3, 2001 Jan-Feb.
(Diagnosis, Pathogenesis, Vaccines & Drugs)
2235. Anonymous. From the Centers for Disease Control and Prevention. Update: outbreak of acute febrile illness among athletes participating in Eco-Challenge-Sabah 2000--Borneo, Malaysia, 2000. JAMA. 285(6):728-30, 2001 Feb 14. 2236. Manea SJ. Sasaki DM. Ikeda JK. Bruno PP. Clinical and epidemiological observations regarding the 1998 Kauai murine typhus outbreak. Hawaii Medical Journal. 60(1):7-11, 2001 Jan. 2237. Petersen AM. Boye K. Blom J. Schlichting P. Krogfelt KA. First isolation of Leptospira fainei serovar Hurstbridge from two human patients with Weil's syndrome. Journal of Medical Microbiology. 50(1):96-100, 2001 Jan. 2238. Smits HL. Eapen CK. Sugathan S. Kuriakose M. Gasem MH. Yersin C. Sasaki D. Pujianto B. Vestering M. Abdoel TH. Gussenhoven GC. Lateral-flow assay for rapid serodiagnosis of human leptospirosis. Clinical & Diagnostic Laboratory Immunology. 8(1):166-9, 2001 Jan. 2239. Smits HL. Chee HD. Eapen CK. Kuriakose M. Sugathan S. Gasem MH. Yersin C. Sakasi D. Lai-A-Fat RF. Hartskeerl RA. Liesdek B. Abdoel TH. Goris MG. Gussenhoven GC. Latex based, rapid and easy assay for human leptospirosis in a single test format. Tropical Medicine & International Health. 6(2):114-8, 2001 Feb. 2240. Sorabjee JS. The liver in enteric fever and leptospirosis. [Review] [13 refs] Indian Journal of Gastroenterology. 20 Suppl 1:C44-6, 2001 Mar. 2241. Zochowski WJ. Palmer MF. Coleman TJ. An evaluation of three commercial kits for use as screening methods for the detection of leptospiral antibodies in the UK. Journal of Clinical Pathology. 54(1):25-30, 2001 Jan.
(Diagnosis, Pathogenesis, Vaccines & Drugs)
2242. Cignarelli M. Triggiani V. Ciampolillo A. Ambrosi A. Giorgino F. Liso V. Giorgino R. High frequency of incidental diagnosis of extrathyroidal neoplastic diseases at the fine-needle aspiration biopsy of laterocervical lymph nodes in patients with thyroid nodules. Thyroid. 11(1):65-71, 2001 Jan. 2243. De Baere T. Moerman M. Rigouts L. Dhooge C. Vermeersch H. Verschraegen G. Vaneechoutte M. Mycobacterium interjectum as causative agent of cervical lymphadenitis. [Review] [16 refs] Journal of Clinical Microbiology. 39(2):725-7, 2001 Feb. 2244. Jha BC. Dass A. Nagarkar NM. Gupta R. Singhal S. Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgraduate Medical Journal. 77(905):185-7, 2001 Mar. 2245. Kawashima H. Nishimata S. Shimizu T. Kashiwagi Y. Takekuma K. Hoshika A. Highly suspected case of FAPA (periodic fever, aphthous stomatitis, pharyngitis and adenitis) syndrome. Pediatrics International. 43(1):103-6, 2001 Feb. 2246. Malich A. Fritsch T. Mauch C. Boehm T. Freesmeyer M. Fleck M. Anderson R. Kaiser WA. Electrical impedance scanning: a new technique in the diagnosis of lymph nodes in which malignancy is suspected on ultrasound. British Journal of Radiology. 74(877):42-7, 2001 Jan. 2247. Mueller PS. Edson RS. Disseminated Mycobacterium abscessus infection manifesting as fever of unknown origin and intra-abdominal lymphadenitis: case report and literature review. [Review] [49 refs] Diagnostic Microbiology & Infectious Disease. 39(1):33-7, 2001 Jan. 2248. Nuovo GJ. Morrison C. Porcu P. Caligiuri MA. Suster S. In situ determination of T-cell receptor beta expression patterns. Journal of Histochemistry & Cytochemistry. 49(2):139-45, 2001 Feb. 2249. Shimizu K. Ito I. Sasaki H. Takada E. Sunagawa M. Masawa N. Fine needle aspiration of toxoplasmic lymphadenitis in an intramammary lymph node. A case report. Acta Cytologica. 45(2):259-62, 2001 Mar-Apr. (Diagnosis,
Pathogenesis, Vaccines & Drugs) 2250.
Afzaal S.
Singh M. Fatima S. Koshy
AA. Rapid diagnostic tests for malaria.
Journal of the Association of Physicians of India.
49:261-5, 2001 Feb. 2251.
Ambe JP.
Fatunde JO. Sodeinde
OO. Associated morbidities in
children with sickle-cell anaemia presenting with severe anaemia in a
malarious area. Tropical
Doctor. 31(1):26-7, 2001 Jan. 2252.
Anand AC. Liver in
malaria. [Review] [12 refs] Indian
Journal of Gastroenterology. 20
Suppl 1:C37-8, 2001 Mar. 2253.
Attaran
A. Global health agencies' response to malaria. Panel should be set
up to review malaria control proposals from endemic countries. BMJ.
322(7279):174; discussion 174-5, 2001 Jan 20. 2254.
Aucan C.
Traore Y. Fumoux F.
Rihet P. Familial
correlation of immunoglobulin G subclass responses to Plasmodium
falciparum antigens in Burkina Faso. Infection & Immunity.
69(2):996-1001, 2001 Feb. 2255.
Bailo Diallo A.
De Serres G. Beavogui
AH. Lapointe C. Viens
P. Home care of
malaria-infected children of less than 5 years of age in a rural area of
the Republic of Guinea. Bulletin
of the World Health Organization. 79(1):28-32,
2001. 2256.
Bannister LH.
Looking for the exit: How do malaria parasites escape from red blood
cells?. Proceedings of the National Academy of Sciences of the United
States of America. 98(2):383-4,
2001 Jan 16. 2257.
Bates I.
Bedu-Addo G. Jarrett RF. Schulz
T. Wallace S.
Armstrong A. Sheldon
J. Rutherford T. B-lymphotropic
viruses in a novel tropical splenic lymphoma. British Journal of
Haematology. 112(1):161-6,
2001 Jan. 2258.
Beeson JG.
Winstanley PA. McFadden
GI. Brown GV. New agents to combat malaria. [letter; comment].
Nature Medicine. 7(2):149-50, 2001 Feb. 2259.
Ben Mamoun C.
Gluzman IY. Hott C.
MacMillan SK. Amarakone
AS. Anderson DL. Carlton JM. Dame
JB. Chakrabarti D. Martin RK. Brownstein
BH. Goldberg DE. Co-ordinated
programme of gene expression during asexual intraerythrocytic development
of the human malaria parasite Plasmodium falciparum revealed by microarray
analysis. Molecular
Microbiology. 39(1):26-36,
2001 Jan. 2260.
Brabin BJ.
Hakimi M. Pelletier D. An analysis of anemia and pregnancy-related
maternal mortality. [Review] [90 refs]
Journal of Nutrition. 131(2S-2):604S-614S;
discussion 614S-615S, 2001 Feb. 2261.
Brieger WR. Are
people in rural African communities willing to pay for the re-treatment of
insecticide-impregnated nets (ITNs)?. Tropical Medicine &
International Health. 6(1):85-6,
2001 Jan. 2262.
Buchovsky AS.
Campetella O. Russomando
G. Franco L. Oddone
R. Candia N.
Luquetti A. Gonzalez
Cappa SM. Leguizamon MS.
trans-sialidase inhibition assay, a highly sensitive and specific
diagnostic test for Chagas' disease. Clinical & Diagnostic Laboratory
Immunology. 8(1):187-9, 2001
Jan. 2263.
Cahill JD. The
febrile traveler. Medicine & Health, Rhode Island.
84(1):16-8, 2001 Jan. 2264.
Capron A.
Capron M. Dombrowicz D. Riveau
G. Vaccine strategies against schistosomiasis: from concepts to clinical
trials. International
Archives of Allergy & Immunology.
124(1-3):9-15, 2001 Jan-Mar. 2265.
Cavanagh DR.
Dobano C. Elhassan IM. Marsh
K. Elhassan A.
Hviid L. Khalil EA.
Theander TG. Arnot DE.
McBride JS. Differential patterns of human immunoglobulin G
subclass responses to distinct regions of a single protein, the merozoite
surface protein 1 of Plasmodium falciparum.
Infection & Immunity. 69(2):1207-11,
2001 Feb. 2266.
Chitnis CE.
Molecular insights into receptors used by malaria parasites for
erythrocyte invasion. [Review] [75 refs]
Current Opinion in Hematology.
8(2):85-91, 2001 Mar. 2267.
Curtis CF.
Insecticide resistance and mosquito-borne disease. Lancet.
357(9257):656, 2001 Mar 3. 2268.
Deitsch K.
Driskill C. Wellems T.
Transformation of malaria parasites by the spontaneous uptake and
expression of DNA from human erythrocytes. Nucleic Acids Research.
29(3):850-3, 2001 Feb 1. 2269.
Desai DC.
Gupta T. Sirsat RA. Shete
M. Malarial pancreatitis: report of two cases and review of the
literature. [Review] [7 refs] American Journal of Gastroenterology.
96(3):930-2, 2001 Mar. 2270.
Dimopoulos G.
Muller HM. Levashina EA. Kafatos
FC. Innate immune defense
against malaria infection in the mosquito. [Review] [72 refs] Current Opinion in Immunology.
13(1):79-88, 2001 Feb. 2271.
Djimde A.
Doumbo OK. Cortese JF. Kayentao
K. Doumbo S. Diourte Y. Dicko
A. Su XZ.
Nomura T. Fidock DA.
Wellems TE. Plowe CV.
Coulibaly D. A
molecular marker for chloroquine-resistant falciparum malaria. [see
comments]. New England
Journal of Medicine. 344(4):257-63,
2001 Jan 25. 2272.
Etchegorry MG.
Matthys F. Galinski M.
White NJ. Nosten F.
Malaria epidemic in Burundi. Lancet.
357(9261):1046-7, 2001 Mar 31. 2273.
Fang CT.
Chang HL. Hsieh WC. Malaria
eradication on islands. Lancet. 357(9255):560,
2001 Feb 17. 2274.
Franks S.
Koram KA. Wagner GE. Tetteh
K. McGuinness D. Wheeler JG. Nkrumah
F. Ranford-Cartwright L.
Riley EM. Frequent and persistent, asymptomatic Plasmodium
falciparum infections in African infants, characterized by multilocus
genotyping. Journal of
Infectious Diseases. 183(5):796-804,
2001 Mar 1. 2275.
Gautret P.
Legros F. Koulmann P. Rodier
MH. Jacquemin JL. Imported
Plasmodium vivax malaria in France: geographical origin and report of an
atypical case acquired in Central or Western Africa.
Acta Tropica. 78(2):177-81,
2001 Feb 23. 2276.
Gautret P.
Plasmodium falciparum gametocyte periodicity. Acta Tropica.
78(1):1-2, 2001 Jan 15. 2277.
Ghosh K.
Javeri KN. Mohanty D.
Parmar BD. Surati RR.
Joshi SH. False-positive
serological tests in acute malaria. British
Journal of Biomedical Science. 58(1):20-3,
2001. 2278.
James AA. Present
and future control of malaria. Science.
291(5503):435-6, 2001 Jan 19. 2279.
Jouin H.
Rogier C. Trape JF.
Mercereau-Puijalon O. Fixed,
epitope-specific, cytophilic antibody response to the polymorphic block 2
domain of the Plasmodium falciparum merozoite surface antigen MSP-1 in
humans living in a malaria-endemic area.
European Journal of Immunology.
31(2):539-50, 2001 Feb. 2280.
Kamat VR.
Private practitioners and their role in the resurgence of malaria
in Mumbai (Bombay) and Navi Mumbai (New Bombay), India: serving the
affected or aiding an epidemic?. Social Science & Medicine.
52(6):885-909, 2001 Mar. 2281.
Kramer MH. Lobel
HO. Antimalarial chemoprophylaxis in infants and children. [Review] [58
refs] Paediatric Drugs.
3(2):113-21, 2001. 2282.
Kristiansen M.
Graversen JH. Jacobsen
C. Sonne O.
Hoffman HJ. Law SK.
Moestrup SK. Identification of the haemoglobin scavenger receptor.
[see comments]. Nature. 409(6817):198-201,
2001 Jan 11. 2283.
Lee CS.
Salcedo E. Wang Q.
Wang P. Sims PF.
Hyde JE. Characterization of three genes encoding enzymes of the
folate biosynthetic pathway in Plasmodium falciparum.
Parasitology. 122 Pt
1:1-13, 2001 Jan. 2284.
Lee HK.
Lim J. Kim M.
Lee S. Oh EJ.
Lee J. Oh J.
Kim Y. Han K.
Lee EJ. Kang CS.
Kim BK. Immunological
alterations associated with Plasmodium vivax malaria in South Korea.
Annals of Tropical Medicine & Parasitology.
95(1):31-9, 2001 Jan. 2285.
Lengeler C.
Comparison of malaria control interventions.
Bulletin of the World Health Organization.
79(1):77, 2001. 2286.
Letvin NL.
Bloom BR. Hoffman SL. Prospects for vaccines to protect against AIDS,
tuberculosis, and malaria. JAMA. 285(5):606-11,
2001 Feb 7. 2287.
May J.
Lell B. Luty AJ.
Meyer CG. Kremsner PG.
HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium
falciparum liver stage antigen 1 protect against malaria anemia and
reinfections. Journal of
Infectious Diseases. 183(1):168-72,
2001 Jan 1. 2288.
McCarthy M.
Should visits to relatives carry a health warning?.
Lancet. 357(9259):862,
2001 Mar 17. 2289.
Menan H.
Dakoury-Dogbo N. Rouet F. Huet C.
Anglaret X. Cotrimo-CI
study group. HIV-1 infection
and malaria parasitaemia. Lancet. 357(9251):233,
2001 Jan 20. 2290.
Miao WM.
Vasile E. Lane WS.
Lawler J. CD36 associates with CD9 and integrins on human blood
platelets. Blood. 97(6):1689-96,
2001 Mar 15. 2291.
Migot-Nabias F.
Luty AJ. Minh TN. Fajardy
I. Tamouza R.
Marzais F. Charron D.
Danze PM. Renaut A.
Deloron P. HLA alleles in relation to specific immunity to liver
stage antigen-1 from plasmodium falciparum in Gabon. Genes & Immunity.
2(1):4-10, 2001 Feb. 2292.
Mockenhaupt FP.
May J. Bergqvist Y. Meyer
CG. Falusi AG.
Bienzle U. Evidence for a reduced effect of chloroquine against
Plasmodium falciparum in alpha-thalassaemic children.
Tropical Medicine & International Health.
6(2):102-7, 2001 Feb. 2293.
Nabarro D.
Roberfroid A. Pannenborg
O. Global health agencies' response to malaria. Agencies dispute
Attaran's view of Roll Back Malaria initiative. BMJ. 322(7279):174-5,
2001 Jan 20. 2294.
Nacher M.
Singhasivanon P. Vannaphan S. Treeprasertsuk
S. Phanumaphorn M.
Traore B. Looareesuwan S. Gay
F. Socio-economic and
environmental protective/risk factors for severe malaria in Thailand. Acta
Tropica. 78(2):139-46, 2001
Feb 23. 2295.
Nardin EH.
Calvo-Calle JM. Oliveira
GA. Nussenzweig RS. Schneider
M. Tiercy JM. Loutan L. Hochstrasser
D. Rose K. A totally
synthetic polyoxime malaria vaccine containing Plasmodium falciparum B
cell and universal T cell epitopes elicits immune responses in volunteers
of diverse HLA types. Journal
of Immunology. 166(1):481-9,
2001 Jan 1. 2296.
Ndounga M.
Basco LK. Ringwald P. Evaluation
of a new sulfadoxine sensitivity assay in vitro for field isolates of
Plasmodium falciparum. Transactions
of the Royal Society of Tropical Medicine & Hygiene.
95(1):55-7, 2001 Jan-Feb. 2297.
Oliveira-Ferreira
J. Daniel-Ribeiro C.
Protective CD8+ T cell responses against the pre-erythrocytic
stages of malaria parasites: an overview. [Review] [56 refs]
Memorias do Instituto Oswaldo Cruz.
96(2):221-7, 2001 Feb. 2298.
Park JW.
Moon SH. Yeom JS.
Lim KJ. Sohn MJ.
Jung WC. Cho YJ.
Jeon KW. Ju W.
Ki CS. Oh MD.
Choe K. Naturally acquired antibody responses to the C-terminal
region of merozoite surface protein 1 of Plasmodium vivax in Korea.
Clinical & Diagnostic Laboratory Immunology.
8(1):14-20, 2001 Jan. 2299.
Parola P.
Ranque S. Badiaga S. Niang
M. Blin O.
Charbit JJ. Delmont J.
Brouqui P. Controlled
trial of 3-day quinine-clindamycin treatment versus 7-day quinine
treatment for adult travelers with uncomplicated falciparum malaria
imported from the tropics. Antimicrobial
Agents & Chemotherapy. 45(3):932-5, 2001 Mar. 2300.
Perkins DJ.
Kremsner PG. Weinberg
JB. Inverse relationship of plasma prostaglandin E2 and blood mononuclear
cell cyclooxygenase-2 with disease severity in children with Plasmodium
falciparum malaria. Journal of Infectious Diseases.
183(1):113-8, 2001 Jan 1. 2301.
Pillai DR.
Labbe AC. Vanisaveth V. Hongvangthong
B. Pomphida S.
Inkathone S. Zhong K. Kain
KC. Plasmodium falciparum
malaria in Laos: chloroquine treatment outcome and predictive value of
molecular markers. Journal of
Infectious Diseases. 183(5):789-95,
2001 Mar 1. 2302.
Proux S.
Hkirijareon L. Ngamngonkiri C. McConnell
S. Nosten F. Paracheck-Pf: a
new, inexpensive and reliable rapid test for P. falciparum malaria.
Tropical Medicine & International Health.
6(2):99-101, 2001 Feb. 2250.
Salmon BL.
Oksman A. Goldberg DE. Malaria parasite exit from the host erythrocyte:
a two-step process requiring extraerythrocytic proteolysis.
Proceedings of the National Academy of Sciences of the United
States of America. 98(1):271-6,
2001 Jan 2. 2251.
Schluesener HJ. Kremsner
PG. Meyermann R. Heme
oxygenase-1 in lesions of human cerebral malaria. Acta Neuropathologica.
101(1):65-8, 2001 Jan. 2252.
Sharma P.
Sharma JD. A review of plant species assessed in vitro for antiamoebic
activity or both antiamoebic and antiplasmodial properties. [Review] [60
refs] Phytotherapy Research.
15(1):1-17, 2001 Feb. 2253.
Sowunmi A.
Adedeji AA. Sowunmi
CO. Falade CO.
Falade AG. Ohaeri B.
Happi TC. Oduola AM.
Clinical characteristics and disposition kinetics of the hepatomegaly
associated with acute, uncomplicated, Plasmodium falciparum malaria in
children. Annals of Tropical
Medicine & Parasitology. 95(1):7-18,
2001 Jan. 2254.
Stevenson MM.
Su Z. Sam H. Mohan K.
Modulation of host responses to blood-stage malaria by interleukin-12:
from therapy to adjuvant activity. [Review] [77 refs]
Microbes & Infection. 3(1):49-59,
2001 Jan. 2255.
Thellier M.
Lusina D. Guiguen C. Delamaire
M. Legros F. Ciceron L. Klerlein
M. Danis M. Mazier D. Is airport malaria a transfusion-transmitted
malaria risk?. Transfusion. 41(2):301-2,
2001 Feb. 2256.
Tkachuk AN.
Moormann AM. Poore JA.
Rochford RA. Chensue
SW. Mwapasa V.
Meshnick SR. Malaria enhances expression of CC chemokine receptor 5
on placental macrophages. Journal of Infectious Diseases.
183(6):967-72, 2001 Mar 15. 2257.
Van den Ende J.
Morales I. Van den Abbeele K. Clerinx
J. Colebunders R.
Kager P. Lynen L.
Van Gompel A. Van der
Planken M. Vervoort T. Changing epidemiological and clinical aspects of
imported malaria in Belgium. Journal
of Travel Medicine. 8(1):19-25,
2001 Jan-Feb. 2258.
van Wendel de
Joode B. Wesseling C.
Kromhout H. Monge P.
Garcia M. Mergler D.
Chronic nervous-system effects of long-term occupational exposure to DDT.
Lancet. 357(9261):1014-6, 2001 Mar 31. 2259.
Verhoef H.
Veenemans J. West CE.
HIV-1 infection and malaria parasitaemia.
Lancet. 357(9251):232-3,
2001 Jan 20. 2260.
Wabwire-Mangen F.
Gray RH. Wawer MJ. Sewankambo
N. Serwadda D HIV-1 infection and malaria parasitaemia.
Lancet. 357(9251):233,
2001 Jan 20. 2261.
Ward SA.
Bray PG. Is reversal
of chloroquine resistance ready for the clinic?.
Lancet. 357(9260):904,
2001 Mar 24. 2262.
Warhurst DC.
A molecular marker for chloroquine-resistant falciparum malaria.
[letter; comment]. New England Journal of Medicine.
344(4):299-302, 2001 Jan 25. 2263.
Watanabe J.
Sasaki M. Suzuki Y. Sugano
S. FULL-malaria: a database
for a full-length enriched cDNA library from human malaria parasite,
Plasmodium falciparum. Nucleic Acids Research.
29(1):70-1, 2001 Jan 1. 2264.
Weisman S.
Wang L. Billman-Jacobe H. Nhan
DH. Richie TL.
Coppel RL. Antibody responses to infections with strains of
Plasmodium falciparum expressing diverse forms of merozoite surface
protein 2. Infection &
Immunity. 69(2):959-67, 2001
Feb. 2265.
Worku S.
Troye-Blomberg M. Christensson B. Bjorkman
A. Fehniger T.
Activation of T cells in the blood of patients with acute malaria:
proliferative activity as indicated by Ki-67 expression.
Scandinavian Journal of Immunology.
53(3):296-301, 2001 Mar. 2266. Yanze MF. Duru C. Jacob M. Bastide JM. Lankeuh M. Rapid therapeutic response onset of a new pharmaceutical form of chloroquine phosphate 300 mg: effervescent tablets. Tropical Medicine & International Health. 6(3):196-201, 2001 Mar. (Diagnosis,
Pathogenesis, Vaccines & Drugs) 2320. Anonymous. Meningococcal disease, African meningitis belt. Weekly Epidemiological Record. 76(8):57, 2001 Feb 23. 2321. Aponso D. Bullen C. Presenting features of meningococcal disease, public health messages and media publicity: are they consistent?. New Zealand Medical Journal. 114(1127):83-5, 2001 Mar 9. 2322. Aronin SI. Quagliarello VJ. New perspectives on pneumococcal meningitis. [Review] [11 refs] Hospital Practice (Office Edition). 36(2):43-6, 49-50, 51, 2001 Feb 15. 2323. Awasthi M. Patankar T. Shah P. Castillo M. Cerebral cryptococcosis: atypical appearances on CT. British Journal of Radiology. 74(877):83-5, 2001 Jan. 2324. Bichile LS. Gokhale YA. Sridhar V. Gill NH. Disseminated cryptococcal infection in immune competent patients. Journal of the Association of Physicians of India. 49:377-8, 2001 Mar. 2325. Birmingham K. UK immunization highs and lows. Nature Medicine. 7(2):135, 2001 Feb. 2326. Boras A. Bozinovic D. Tenover FC. Popovic T. First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia. Journal of Clinical Microbiology. 39(2):823, 2001 Feb. 2327. Chang DZ. Correia NG. Khurana P. Tuthill RJ. Taege AJ. A 35-year-old man with recurrent aseptic meningitis. Cleveland Clinic Journal of Medicine. 68(3):199-201, 205-6, 2001 Mar. 2328. Chin-Hong PV. Sutton DA. Roemer M. Jacobson MA. Aberg JA. Invasive fungal sinusitis and meningitis due to Arthrographis kalrae in a patient with AIDS. Journal of Clinical Microbiology. 39(2):804-7, 2001 Feb. 2329. Cullington HE. Light eye colour linked to deafness after meningitis. BMJ. 322(7286):587, 2001 Mar 10. 2330. Evershed K. de Wit D. An unusual presentation of fatal invasive meningococcal disease. Australian Family Physician. 30(3):248-51, 2001 Mar. 2331. Fobelo MJ. Corzo Delgado JE. Romero Alonso A. Gomez-Bellver MJ. Aseptic meningitis related to valacyclovir. Annals of Pharmacotherapy. 35(1):128-9, 2001 Jan. 2332. Forgacs P. Geyer CA. Freidberg SR. Characterization of chemical meningitis after neurological surgery. Clinical Infectious Diseases. 32(2):179-85, 2001 Jan 15. 2333. Ghosal N. Kapila K. Kakkar S. Verma K. Langerhans cell histiocytosis infiltration in cerebrospinal fluid: a case report. Diagnostic Cytopathology. 24(2):123-5, 2001 Feb. 2334. Gnanalingham MG. Clarke MA. Primary Staphylococcus aureus meningitis in an infant. Journal of the Royal Society of Medicine. 94(2):86-8, 2001 Feb. 2335. Gordon SM. Should all college-bound freshmen receive meningococcal vaccine?. Cleveland Clinic Journal of Medicine. 68(1):9-10, 2001 Jan. 2336. Grossman SA. Celano P. Images in clinical medicine. Neoplastic meningitis. New England Journal of Medicine. 344(7):494, 2001 Feb 15. 2337. Haase KK. Lapointe M. Haines SJ. Aseptic meningitis after intraventricular administration of gentamicin. Pharmacotherapy. 21(1):103-7, 2001 Jan. 2338. Holt DE. Halket S. de Louvois J. Harvey D. Neonatal meningitis in England and Wales: 10 years on. Archives of Disease in Childhood Fetal & Neonatal Edition. 84(2):F85-9, 2001 Mar. 2339. Hoque SN. Graham J. Kaufmann ME. Tabaqchali S. Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. Journal of Hospital Infection. 47(3):188-92, 2001 Mar. 2340. Johnson JR. Delavari P. O'Bryan TT. Escherichia coli O18:K1:H7 isolates from patients with acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profiles. Journal of Infectious Diseases. 183(3):425-434, 2001 Feb 1. 2341. Kawashima M. Suzuki SO. Yamashima T. Fukui M. Iwaki T. Prostaglandin D synthase (beta-trace) in meningeal hemangiopericytoma. Modern Pathology. 14(3):197-201, 2001 Mar. 2342. Kurup A. Tee WS. Loo LH. Lin R. Infection of central nervous system by motile Enterococcus: first case report. Journal of Clinical Microbiology. 39(2):820-2, 2001 Feb. 2343. Lai KK. Enterobacter sakazakii infections among neonates, infants, children, and adults. Case reports and a review of the literature. [Review] [41 refs] Medicine. 80(2):113-22, 2001 Mar. 2320. Liebeskind DS. Ostrzega N. Wasterlain CG. Buttner EA. Neurologic manifestations of disseminated infection with Mycobacterium abscessus. Neurology. 56(6):810-3, 2001 Mar 27. 2321. Lortholary O. Dromer F. Mathoulin-Pelissier S. Fitting C. Improvisi L. Cavaillon JM. Dupont B. French Cryptococcosis Study Group. Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus. Journal of Infectious Diseases. 183(2):294-302, 2001 Jan 15. 2322. MacLennan J. Obaro S. Deeks J. Lake D. Elie C. Carlone G. Moxon ER. Greenwood B. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy. Journal of Infectious Diseases. 183(1):97-104, 2001 Jan 1. 2323. Manfredi R. Nanetti A. Valentini R. Chiodo F. Acinetobacter infections in patients with human immunodeficiency virus infection: microbiological and clinical epidemiology. Chemotherapy. 47(1):19-28, 2001 Jan-Feb. 2324. McMinn P. Stratov I. Nagarajan L. Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clinical Infectious Diseases. 32(2):236-42, 2001 Jan 15. 2325. Merkelbach S. Konig J. Rohn S. Muller M. The use of clinical scales in depicting cerebrovascular complications in bacterial meningitis. Journal of Neuroimaging. 11(1):25-9, 2001 Jan. 2326. Muller MP. Richardson DC. Walmsley SL. Trimethoprim-sulfamethoxazole induced aseptic meningitis in a renal transplant patient. [Review] [20 refs] Clinical Nephrology. 55(1):80-4, 2001 Jan. 2327. Nelson DA. Landau WM. Intrathecal methylprednisolone for postherpetic neuralgia. New England Journal of Medicine. 344(13):1019; discussion 1021-2, 2001 Mar 29. 2328. Panciera RJ. Ewing SA. Confer AW. Ocular histopathology of Ehrlichial infections in the dog. Veterinary Pathology. 38(1):43-6, 2001 Jan. 2329. Ratka A. Erramouspe J. Intramuscular ceftriaxone in the treatment of childhood meningitis due to Haemophilus influenzae type F. Annals of Pharmacotherapy. 35(1):36-40, 2001 Jan. 2330. Ravenscroft A. Schoeman JF. Donald PR. Tuberculous granulomas in childhood tuberculous meningitis: radiological features and course. Journal of Tropical Pediatrics. 47(1):5-12, 2001 Feb. 2331. Rees JH. Balakas N. Agathonikou A. Hain SF. Giovanonni G. Panayiotopoulos CP. Luxsuwong M. Revesz T. Primary diffuse leptomeningeal gliomatosis simulating tuberculous meningitis. Journal of Neurology, Neurosurgery & Psychiatry. 70(1):120-2, 2001 Jan. 2332. Sacktor N. Lyles RH. Skolasky R. Kleeberger C. Selnes OA. Miller EN. Becker JT. Cohen B. McArthur JC. The Multicenter AIDS Cohort Study. HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology. 56(2):257-60, 2001 Jan 23. 2333. Sakhuja V. Sud K. Kalra OP. D'Cruz S. Kohli HS. Jha V. Gupta K. Vasishta RK. Central nervous system complications in renal transplant recipients in a tropical environment. Journal of the Neurological Sciences. 183(1):89-93, 2001 Jan 15. 2334. Socan M. Ravnik I. Bencina D. Dovc P. Zakotnik B. Jazbec J. Neurological symptoms in patients whose cerebrospinal fluid is culture- and/or polymerase chain reaction-positive for Mycoplasma pneumoniae. Clinical Infectious Diseases. 32(2):E31-5, 2001 Jan 15. 2335. Tinsley C. Nassif X. Meningococcal pathogenesis: at the boundary between the pre- and post-genomic eras. [Review] [49 refs] Current Opinion in Microbiology. 4(1):47-52, 2001 Feb. 2336. Van Acker JT. Delanghe JR. Langlois MR. Taes YE. De Buyzere ML. Verstraete AG. Automated flow cytometric analysis of cerebrospinal fluid. Clinical Chemistry. 47(3):556-60, 2001. 2337. Wadia RS. Pujari SN. Kothari S. Udhar M. Kulkarni S. Bhagat S. Nanivadekar A. Neurological manifestations of HIV disease. Journal of the Association of Physicians of India. 49:343-8, 2001 Mar. 2338. Wang CC. Siu LK. Chen MK. Yu YL. Lin FM. Ho M. Chu ML. Use of automated riboprinter and pulsed-field gel electrophoresis for epidemiological studies of invasive Haemophilus influenzae in Taiwan. Journal of Medical Microbiology. 50(3):277-83, 2001 Mar. 2339. Wong M. Schlaggar BL. Landt M. Postictal cerebrospinal fluid abnormalities in children. Journal of Pediatrics. 138(3):373-7, 2001 Mar.
(Diagnosis, Pathogenesis, Vaccines & Drugs) 2364.
Adds PJ.
Hunt C. Hartley S.
Bacterial contamination of amniotic membrane.
British Journal of Ophthalmology.
85(2):228-30, 2001 Feb. 2365.
Al-Qurashi AR.
El-Morsy F. Al-Quorain
AA. Evolution of metronidazole and tetracycline susceptibility pattern in
Helicobacter pylori at a hospital in Saudi Arabia. International Journal
of Antimicrobial Agents. 17(3):233-6,
2001 Mar. 2366.
Almuneef MA.
Baltimore RS. Farrel
PA. Reagan-Cirincione P.
Dembry LM. Molecular
typing demonstrating transmission of gram-negative rods in a neonatal
intensive care unit in the absence of a recognized epidemic.
Clinical Infectious Diseases.
32(2):220-7, 2001 Jan 15. 2367.
Astagneau P.
Brucker G. Organization of hospital-acquired infection control in
France. Journal of Hospital Infection.
47(2):84-7, 2001 Feb. 2368.
Bauer TM.
Lalvani A. Fehrenbach
J. Steffen I. Aponte
JJ. Segovia R.
Vila J. Philippczik G.
Steinbruckner B. Frei
R. Bowler I. Kist
M. Derivation and validation of guidelines for stool cultures for
enteropathogenic bacteria other than Clostridium difficile in hospitalized
adults. JAMA.
285(3):313-9, 2001 Jan 17. 2369.
Cazzola M.
Blasi E. Allegra L. Critical
evaluation of guidelines for the treatment of lower respiratory tract
bacterial infections. Respiratory
Medicine. 95(2):95-108, 2001
Feb. 2370.
Chandra PN.
Milind K. Lapses in measures recommended for preventing
hospital-acquired infection. Journal
of Hospital Infection. 47(3):218-22,
2001 Mar. 2371.
Cunha BA.
Nosocomial pneumonia. Diagnostic and therapeutic considerations.
[Review] [167 refs] Medical Clinics of North America. 85(1):79-114, 2001 Jan. 2372.
D'Agata EM.
Wise S. Stewart A. Lefkowitz
LB Jr. Nosocomial transmission of Mycobacterium tuberculosis from an
extrapulmonary site. Infection
Control & Hospital Epidemiology.
22(1):10-2, 2001 Jan. 2373.
D'Agata EM.
Green WK. Schulman G. Li
H. Tang YW.
Schaffner W. Vancomycin-resistant enterococci among chronic
hemodialysis patients: a prospective study of acquisition.
Clinical Infectious Diseases.
32(1):23-9, 2001 Jan. 2374.
Fiel S.
Guidelines and critical pathways for severe hospital-acquired
pneumonia. [Review] [24 refs] Chest. 119(2
Suppl):412S-418S, 2001 Feb. 2375.
Gopal Rao G.
Ozerek AE. Jeanes A. Rational
protocols for testing faeces in the investigation of sporadic
hospital-acquired diarrhoea. [Review] [15 refs]
Journal of Hospital Infection.
47(2):79-83, 2001 Feb. 2376.
Griffiths RD.
Bradley P. Guiding
hands of our teachers. Lancet.
357(9254):479, 2001 Feb 10. 2377.
Koksal N.
Hacimustafaoglu M. Bagci
S. Celebi S. Meropenem in
neonatal severe infections due to multiresistant gram-negative bacteria.
Indian Journal of Pediatrics.
68(1):15-9, 2001 Jan. 2378.
Kollef MH.
Fraser VJ. Antibiotic
resistance in the intensive care unit. [Review] [203 refs]
Annals of Internal Medicine. 134(4):298-314,
2001 Feb 20. 2379.
Lamoste TJ.
Chapnick EK. Protic
JR. Hernandez JE.
Gerard PS. Radiographic
films: potential source of nosocomial infections?.
Infection Control & Hospital Epidemiology.
22(2):66, 2001 Feb. 2380.
Lui SL.
Luk WK. Cheung CY.
Chan TM. Lai KN.
Peiris JS. Nosocomial
outbreak of parvovirus B19 infection in a renal transplant unit.
Transplantation. 71(1):59-64, 2001 Jan 15. 2381.
Lynch JP 3rd.
Hospital-acquired pneumonia: risk factors, microbiology, and treatment.
[Review] [105 refs] Chest.
119(2 Suppl):373S-384S, 2001 Feb. 2382.
Lynch JP 3rd.
Antimicrobial resistance: it's time to reverse the trend. Chest.
119(2 Suppl):371S-372S, 2001 Feb. 2383.
Mintjes J.
Boldewijn W. Aerts G.
Sparnaay M. Train the trainers course on infection control and
hospital hygiene in Bangladesh. Tropical Doctor.
31(1):36-7, 2001 Jan. 2384.
Murthy R.
Implementation of strategies to control antimicrobial resistance.
Chest. 119(2 Suppl):405S-411S,
2001 Feb. 2385.
Naikoba S.
Hayward A. The effectiveness of interventions aimed at increasing
handwashing in healthcare workers - a systematic review. [Review] [32
refs] Journal of Hospital
Infection. 47(3):173-80, 2001
Mar. 2386.
Napolitano LM.
Greco ME. Rodriguez A. Kufera
JA. West RS. Scalea TM. Gender differences in adverse outcomes after blunt
trauma. Journal of
Trauma-Injury Infection & Critical Care.
50(2):274-80, 2001 Feb. 2387.
Newman MJ.
Infection control in Africa south of the Sahara.
Infection Control & Hospital Epidemiology.
22(2):68-9, 2001 Feb. 2388.
Obasanjo OO.
Wu P. Conlon M. Karanfil
LV. Pryor P. Moler G. Anhalt
G. Chaisson RE. Perl TM. An outbreak of scabies in a teaching hospital:
lessons learned. Infection
Control & Hospital Epidemiology.
22(1):13-8, 2001 Jan. 2389.
Palabiyikoglu I.
Oral M. Tulunay M. Candida colonization in mechanically ventilated
patients. Journal of Hospital
Infection. 47(3):239-42, 2001
Mar. 2390.
Patterson JE.
Antibiotic utilization: is there an effect on antimicrobial resistance?.
[Review] [21 refs] Chest.
119(2 Suppl):426S-30S, 2001 Feb. 2391.
Petros AJ.
O'Connell M. Roberts
C. Wade P.
van Saene HK. Systemic
antibiotics fail to clear multidrug-resistant Klebsiella from a pediatric
ICU. Chest. 119(3):862-6,
2001 Mar. 2392.
Piro S.
Sammud M. Badi S.
Al Ssabi L. Hospital-acquired
malaria transmitted by contaminated gloves.
Journal of Hospital Infection.
47(2):156-8, 2001 Feb. 2393.
Pournaras S.
Slavakis A. Polyzou A.
Sofianou D. Maniatis
AN. Tsakris A.
Nosocomial spread of an unusual methicillin-resistant
Staphylococcus aureus clone that is sensitive to all non-beta-lactam
antibiotics, including tobramycin. Journal
of Clinical Microbiology. 39(2):779-81,
2001 Feb. 2394.
Richard VS.
John TJ. Kenneth J. Ramaprabha
P. Kuruvilla PJ.
Chandy GM. Should health care workers in the tropics be immunized
against varicella?. Journal
of Hospital Infection. 47(3):243-5,
2001 Mar. 2395.
Rivero A.
Marquez M. Santos J. Pinedo
A. Sanchez MA.
Esteve A. Samper S.
Martin C. High rate of
tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant
tuberculosis caused by Mycobacterium bovis strain B.
Clinical Infectious Diseases.
32(1):159-61, 2001 Jan. 2396.
San Pedro G. Are
quantitative cultures useful in the diagnosis of hospital-acquired
pneumonia?. Chest. 119(2
Suppl):385S-390S, 2001 Feb. 2397.
Slota M.
Green M. Farley A.
Janosky J. Carcillo J.
The role of gown and glove isolation and strict handwashing in the
reduction of nosocomial infection in children with solid organ
transplantation. [see comments]. Critical
Care Medicine. 29(2):405-12,
2001 Feb. 2398.
Taylor GS.
Vipond IB. Caul EO.
Molecular epidemiology of outbreak of respiratory syncytial virus within
bone marrow transplantation unit. Journal
of Clinical Microbiology. 39(2):801-3,
2001 Feb. 2399.
Trautmann M.
Michalsky T. Wiedeck
H. Radosavljevic V.
Ruhnke M. Tap water colonization with Pseudomonas aeruginosa in a
surgical intensive care unit (ICU) and relation to Pseudomonas infections
of ICU patients. Infection
Control & Hospital Epidemiology.
22(1):49-52, 2001 Jan. 2400.
Tubbs D.
Lenney W. Alcock P.
Campbell CA. Gray J.
Pantin C. Pseudomonas
aeruginosa in cystic fibrosis: cross-infection and the need for
segregation. Respiratory
Medicine. 95(2):147-52, 2001
Feb. 2401.
Vastag B.
New vaccine decreases rate of nosocomial infections.
JAMA. 285(12):1565-6,
2001 Mar 28. 2402.
Vehmeyer SB.
Bloem RM. Petit PL. Microbiological
screening of post-mortem bone donors - two case reports.
Journal of Hospital Infection.
47(3):193-7, 2001 Mar. 2403.
Wang JT.
Chang SC. Ko WJ.
Chang YY. Chen ML.
Pan HJ. Luh KT.
A hospital-acquired outbreak of methicillin-resistant
Staphylococcus aureus infection initiated by a surgeon carrier.
Journal of Hospital Infection.
47(2):104-9, 2001 Feb. 2404.
Ward HR.
Jennings OG. Potgieter P. Lombard
CJ. Do plastic adhesive drapes prevent post caesarean wound infection?.
Journal of Hospital Infection.
47(3):230-4, 2001 Mar. 2405. Yardy GW. Cox RA. An outbreak of Pseudomonas aeruginosa infection associated with contaminated urodynamic equipment. Journal of Hospital Infection. 47(1):60-3, 2001 Jan Pneumonia
(Diagnosis, Pathogenesis, Vaccines & Drugs) 2406. Benfield TL. Helweg-Larsen J. Bang D. Junge J. Lundgren JD. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia. Chest. 119(3):844-51, 2001 Mar. 2407. Bhalla A. Unusual clinical manifestations of acute pneumonia. Journal of the Association of Physicians of India. 49:389-90, 2001 Mar. 2408. Christenson B. Lundbergh P. Hedlund J. Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet. 357(9261):1008-11, 2001 Mar 31. 2409. Crippa F. Corey L. Chuang EL. Sale G. Boeckh M. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation. Clinical Infectious Diseases. 32(2):214-9, 2001 Jan 15. 2410. Cunha BA. Nosocomial pneumonia. Diagnostic and therapeutic considerations. [Review] [167 refs] Medical Clinics of North America. 85(1):79-114, 2001 Jan. 2411. Doi M. Takao S. Kaneko K. Karakawa S. Ishihara S. Awaya Y. Kuwabara M. Ishioka S. Yamakido M. Two cases of severe bronchopneumonia due to influenza A (H3N2) virus: detection of influenza virus gene using reverse transcription polymerase chain reaction. Internal Medicine. 40(1):61-7, 2001 Jan. 2412. Engelhardt T. Strachan L. Johnston G. Aspiration and regurgitation prophylaxis in paediatric anaesthesia. Paediatric Anaesthesia. 11(2):147-50, 2001. 2413. Eron LJ. Passos S. Early discharge of infected patients through appropriate antibiotic use. Archives of Internal Medicine. 161(1):61-5, 2001 Jan 8. 2414. Fiel S. Guidelines and critical pathways for severe hospital-acquired pneumonia. [Review] [24 refs] Chest. 119(2 Suppl):412S-418S, 2001 Feb. 2415. Flanagan PG. Jackson SK. Findlay G. Diagnosis of gram negative, ventilator associated pneumonia by assaying endotoxin in bronchial lavage fluid. Journal of Clinical Pathology. 54(2):107-10, 2001 Feb. 2406. Franssila R. Hokynar K. Hedman K. T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19. Journal of Infectious Diseases. 183(5):805-9, 2001 Mar 1. 2407. Grenier A. Combaux D. Chastre J. Gougerot-Pocidalo MA. Gibert C. Dehoux M. Chollet-Martin S. Oncostatin M production by blood and alveolar neutrophils during acute lung injury. Laboratory Investigation. 81(3):133-41, 2001 Feb. 2408. Martinez Garcia MA. de Rojas MD. Nauffal Manzur MD. Munoz Pamplona MP. Compte Torrero L. Macian V. Perpina Tordera M. Respiratory disorders in common variable immunodeficiency. Respiratory Medicine. 95(3):191-5, 2001 Mar. 2409. Mascellino MT. Delogu G. Pelaia MR. Ponzo R. Parrinello R. Giardina A.Reduced bactericidal activity against Staphylococcus aureus and Pseudomonas aeruginosa of blood neutrophils from patients with early adult respiratory distress syndrome Journal of Medical Microbiology. 50(1):49-54, 2001 Jan. 2410. Metersky ML. Fine JM. Tu GS. Mathur D. Weingarten S. Petrillo MK. Meehan TP. Lack of effect of a pneumonia clinical pathway on hospital-based pneumococcal vaccination rates. American Journal of Medicine. 110(2):141-3, 2001 Feb 1. 2411. Muller MP. Richardson DC. Walmsley SL. Trimethoprim-sulfamethoxazole induced aseptic meningitis in a renal transplant patient. [Review] [20 refs] Clinical Nephrology. 55(1):80-4, 2001 Jan. 2412. Munk ME. Arend SM. Brock I. Ottenhoff TH. Andersen P. Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. Journal of Infectious Diseases. 183(1):175-6, 2001 Jan 1. 2413. Nadala D. Bossart W. Zucol F. Steiner F. Berger C. Lips U. Altwegg M. Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR. Diagnostic Microbiology & Infectious Disease. 39(1):15-9, 2001 Jan. 2414. Nelson S. Novel nonantibiotic therapies for pneumonia: cytokines and host defense. [Review] [40 refs] Chest. 119(2 Suppl):419S-425S, 2001 Feb. 2415. Palabiyikoglu I. Oral M. Tulunay M. Candida colonization in mechanically ventilated patients. Journal of Hospital Infection. 47(3):239-42, 2001 Mar. 2416. Pesola GR. The urinary antigen test for the diagnosis of pneumococcal pneumonia. [letter; comment]. Chest. 119(1):9-11, 2001 Jan. 2417. Remiszewski P. Slodkowska J. Wiatr E. Zych J. Radomski P. Rowinska-Zakrzewska E. Fatal infection in patients treated for small cell lung cancer in the Institute of Tuberculosis and Chest Diseases in the years 1980-1994. Lung Cancer. 31(2-3):101-10, 2001 Feb-Mar. 2418. Simsir A. Oldach D. Forest G. Henry M. Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: diagnosis by fine-needle aspiration biopsy. Diagnostic Cytopathology. 24(2):129-31, 2001 Feb. 2419. Snow V. Mottur-Pilson C. Gonzales R. American Academy of Family Physicians. American College of Physicians-American Society of Internal Medicine. Centers for Disease Control. Infectious Diseases Society of America. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Annals of Internal Medicine. 134(6):518-20, 2001 Mar 20. 2420. Suzuki LA. Rocha RJ. Rossi CL. Evaluation of serological markers for the immunodiagnosis of acute acquired toxoplasmosis. Journal of Medical Microbiology. 50(1):62-70, 2001 Jan. 2421. Tamm M. Traenkle P. Grilli B. Soler M. Bolliger CT. Dalquen P. Cathomas G. Pulmonary cytomegalovirus infection in immunocompromised patients. Chest. 119(3):838-43, 2001 Mar. 2422. Tejada Artigas A. Bello Dronda S. Chacon Valles E. Munoz Marco J. Villuendas Uson MC. Figueras P. Suarez FJ. Hernandez A. Risk factors for nosocomial pneumonia in critically ill trauma patients. Critical Care Medicine. 29(2):304-9, 2001 Feb. 2423. Theerthakarai R. El-Halees W. Ismail M. Solis RA. Khan MA. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. [see comments]. Chest. 119(1):181-4, 2001 Jan. 2424. Tuuminen T. Suni J. Kleemola M. Jacobs E. Improved sensitivity and specificity of enzyme immunoassays with P1-adhesin enriched antigen to detect acute Mycoplasma pneumoniae infection. Journal of Microbiological Methods. 44(1):27-37, 2001 Feb 1. 2425. Verheij T. Diagnosis and prognosis of lower respiratory tract infections: a cough is not enough. [letter; comment]. British Journal of General Practice. 51(464):174-5, 2001 Mar. 2426. Waterer GW. Baselski VS. Wunderink RG. Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint. [see comments]. [Review] [88 refs] American Journal of Medicine. 110(1):41-8, 2001 Jan. (Diagnosis, Pathogenesis, Vaccines & Drugs)
2437. Al-Matar MJ. Cabral DA. Petty RE. Isolated tuberculous monoarthritis mimicking oligoarticular juvenile rheumatoid arthritis. Journal of Rheumatology. 28(1):204-6, 2001 Jan. 2438. Berk C. Tuberculosis and the skull. Journal of Neurosurgery. 94(1):146-7, 2001 Jan. 2439. Blomberg B. Spinaci S. Fourie B. Laing R. The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis. Bulletin of the World Health Organization. 79(1):61-8, 2001. 2440. Bora P. Gomber S. Agarwal V. Jain M. Splenic tuberculosis presenting as hypersplenism. Annals of Tropical Paediatrics. 21(1):86-7, 2001 Mar. 2441. Chandrasekhar HR. Shashikala P. Murthy BN. Vidyasagar B. Rao HL. Bronchioloalveolar carcinoma mimicking miliary tuberculosis. Journal of the Association of Physicians of India. 49:281-2, 2001 Feb. 2442. Daley AJ. Non-tuberculous mycobacterial cervical lymphadenopathy. [Review] [22 refs] Journal of Paediatrics & Child Health. 37(1):78-80, 2001 Feb. 2443. Domenech P. Barry CE 3rd. Cole ST. Mycobacterium tuberculosis in the post-genomic age. [Review] [42 refs] Current Opinion in Microbiology. 4(1):28-34, 2001 Feb. 2444. Glickman MS. Jacobs WR Jr. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. [Review] [80 refs] Cell. 104(4):477-85, 2001 Feb 23. 2445. Gomez-Pastrana D. Torronteras R. Caro P. Anguita ML. Lopez-Barrio AM. Andres A. Navarro J. Comparison of amplicor, in-house polymerase chain reaction, and conventional culture for the diagnosis of tuberculosis in children. Clinical Infectious Diseases. 32(1):17-22, 2001 Jan. 2446. Gupta D. Saiprakash BV. Aggarwal AN. Muralidhar S. Kumar B. Jindal SK. Value of different cut-off points of tuberculin skin test to diagnose tuberculosis among patients with respiratory symptoms in a chest clinic. Journal of the Association of Physicians of India. 49:332-5, 2001 Mar. 2447. Hirsch CS. Toossi Z. Johnson JL. Luzze H. Ntambi L. Peters P. McHugh M. Okwera A. Joloba M. Mugyenyi P. Mugerwa RD. Terebuh P. Ellner JJ. Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. Journal of Infectious Diseases. 183(5):779-88, 2001 Mar 1. 2448. Hong SH. Kim SM. Ahn JM. Chung HW. Shin MJ. Kang HS. Tuberculous versus pyogenic arthritis: MR imaging evaluation. Radiology. 218(3):848-53, 2001 Mar. 2449. Jha BC. Dass A. Nagarkar NM. Gupta R. Singhal S. Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgraduate Medical Journal. 77(905):185-7, 2001 Mar. 2450. Kishor D. Garg RK. Mishra S. An unusual case of spinal tuberculosis: role of MR study. Journal of the Association of Physicians of India. 49:295-6, 2001 Feb. 2451. Kiwanuka J. Graham SM. Coulter JB. Gondwe JS. Chilewani N. Carty H. Hart CA. Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi. Annals of Tropical Paediatrics. 21(1):5-14, 2001 Mar. 2452. Klein MR. Smith SM. Hammond AS. Ogg GS. King AS. Vekemans J. Jaye A. Lukey PT. McAdam KP. HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis. Journal of Infectious Diseases. 183(6):928-34, 2001 Mar 15. 2453. Koga T. Kubota Y. Kiryu H. Nakayama J. Matsuzoe D. Shirakusa T. Erythema induratum in a patient with active tuberculosis of the axillary lymph node: IFN-gamma release of specific T cells. European Journal of Dermatology. 11(1):48-9, 2001 Jan-Feb. 2454. Kuyucu N. Kuyucu S. Bakirtas A. Karacan C. BCG revaccination and tuberculin reactivity. Indian Journal of Pediatrics. 68(1):21-5, 2001 Jan. 2455. Lenk S. Schroeder J. Genitourinary tuberculosis. [Review] [17 refs] Current Opinion in Urology. 11(1):93-8, 2001 Jan. 2456. Lewinsohn DM. Zhu L. Madison VJ. Dillon DC. Fling SP. Reed SG. Grabstein KH. Alderson MR. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity. Journal of Immunology. 166(1):439-46, 2001 Jan 1. 2457. Mahboubi S. Morris MC. Imaging of spinal infections in children. [Review] [35 refs] Radiologic Clinics of North America. 39(2):215-22, 2001 Mar. 2458. Moore SL. Rafii M. Imaging of musculoskeletal and spinal tuberculosis. [Review] [49 refs] Radiologic Clinics of North America. 39(2):329-42, 2001 Mar. 2459. Munk ME. Arend SM. Brock I. Ottenhoff TH. Andersen P. Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. Journal of Infectious Diseases. 183(1):175-6, 2001 Jan 1. 2460. Passmore JS. Lukey PT. Ress SR. The human macrophage cell line U937 as an in vitro model for selective evaluation of mycobacterial antigen-specific cytotoxic T-cell function. Immunology. 102(2):146-56, 2001 Feb. 2461. Qureshi RN. Samad S. Hamid R. Lakha SF. Female genital tuberculosis revisted. JPMA - Journal of the Pakistan Medical Association. 51(1):16-8, 2001 Jan. 2462. Raut VS. Mahashur AA. Sheth SS. The Mantoux test in the diagnosis of genital tuberculosis in women. International Journal of Gynaecology & Obstetrics. 72(2):165-9, 2001 Feb. 2463. Research Committee of the British Thoracic Society. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. [see comments]. Thorax. 56(3):167-72, 2001 Mar. 2464. Richter B. Fradis M. Kohler G. Ridder GJ. Epiglottic tuberculosis: differential diagnosis and treatment. Case report and review of the literature. [Review] [32 refs] Annals of Otology, Rhinology & Laryngology. 110(2):197-201, 2001 Feb. 2465. Sakai J. Matsuzawa S. Usui M. Yano I. New diagnostic approach for ocular tuberculosis by ELISA using the cord factor as antigen. [see comments]. British Journal of Ophthalmology. 85(2):130-3, 2001 Feb. 2466. Soler R. Rodriguez E. Remuinan C. Santos M. MRI of musculoskeletal extraspinal tuberculosis. Journal of Computer Assisted Tomography. 25(2):177-83, 2001 Mar-Apr. 2437. Souilamas R. Riquet M. Barthes FP. Chehab A. Capuani A. Faure E. Surgical treatment of active and sequelar forms of pulmonary tuberculosis. Annals of Thoracic Surgery. 71(2):443-7, 2001 Feb. 2438. Toossi Z. Mayanja-Kizza H. Hirsch CS. Edmonds KL. Spahlinger T. Hom DL. Aung H. Mugyenyi P. Ellner JJ. Whalen CW. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clinical & Experimental Immunology. 123(2):233-8, 2001 Feb. 2439. Toyoshima M. Chida K. Suda T. Imokawa S. Nakamura H. Wegener's granulomatosis responding to antituberculous drugs. Chest. 119(2):643-5, 2001 Feb. 2440. Valle MT. Megiovanni AM. Merlo A. Li Pira G. Bottone L. Angelini G. Bracci L. Lozzi L. Huygen K. Manca F. Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85. Clinical & Experimental Immunology. 123(2):226-32, 2001 Feb. 2441. van den Berge M. Tinga CJ. Bieger R. A 73-year-old man with chronic lymphocytic leukaemia and a haemorrhagic pleural effusion. Annals of Hematology. 80(3):183-6, 2001 Mar. 2442. Van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. [Review] [314 refs] Journal of Internal Medicine. 249(1):1-26, 2001 Jan. 2443. Walley JD. Khan MA. Newell JN. Khan MH. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet. 357(9257):664-9, 2001 Mar 3. 2444. Woods GL. Bergmann JS. Williams-Bouyer N. Clinical Evaluation of the Gen-Probe amplified mycobacterium tuberculosis direct test for rapid detection of Mycobacterium tuberculosis in select nonrespiratory specimens. Journal of Clinical Microbiology. 39(2):747-9, 2001 Feb. 2445. Woods GL. Molecular techniques in mycobacterial detection. [Review] [35 refs] Archives of Pathology & Laboratory Medicine. 125(1):122-6, 2001 Jan (Diagnosis, Pathogenesis, Vaccines & Drugs)
2476. Agunwamba JC. Analysis of socioeconomic and environmental impacts of waste stabilization pond and unrestricted wastewater irrigation: interface with maintenance. Environmental Management. 27(3):463-76, 2001 Mar. 2477. Chiu S. Chiu CH. Lin TY. Luo CC. Jaing TH. Septic arthritis of the hip caused by Salmonella typhi. Annals of Tropical Paediatrics. 21(1):88-90, 2001 Mar. 2478. Ebi GC. Kamalu TN. Phytochemical and antimicrobial properties of constituents of "Ogwu Odenigbo", a popular Nigerian herbal medicine for typhoid fever. Phytotherapy Research. 15(1):73-5, 2001 Feb. 2479. Hussein MM. Mooij JM. Roujouleh HM. Hamour OA. Felemban H. Non-typhoid Salmonella septicemia and visceral leishmaniasis in a renal transplant patient. Transplantation. 71(3):479-81, 2001 Feb 15. 2480. Singh H. Singh S. Hypoglycaemia in Salmonella typhi. Tropical Doctor. 31(1):56-7, 2001 Jan. 2481. Sood A. Midha V. Sood N. Massive hemorrhage from colonic ulcers in typhoid fever. Indian Journal of Gastroenterology. 20(2):80, 2001 Mar-Apr. 2482. Sorabjee JS. The liver in enteric fever and leptospirosis. [Review] [13 refs] Indian Journal of Gastroenterology. 20 Suppl 1:C44-6, 2001 Mar. 2483. Yeolekar ME. Gupta H. Persistent fever in a case of typhoid--an unusual cause of neuroleptic malignant syndrome. Journal of the Association of Physicians of India. 49:296, 2001 Feb. Ayurveda & complementary
Systems
of Medicine
(Acupuncture, Alternative medicine, Ayurveda, Complementary medicine, Herbal medicine, Homeopathy, Siddha and Traditional medicine) 2484. Aabel S. Fossheim S. Rise F. Nuclear magnetic resonance (NMR) studies of homeopathic solutions. [see comments]. British Homoeopathic Journal. 90(1):14-20, 2001 Jan. 2485. Ahmad I. Beg AZ. Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens. Journal of Ethnopharmacology. 74(2):113-23, 2001 Feb. 2486. Ali NA. Julich WD. Kusnick C. Lindequist U. Screening of Yemeni medicinal plants for antibacterial and cytotoxic activities. Journal of Ethnopharmacology. 74(2):173-9, 2001 Feb. 2487. Anonymous. Incorporating new (mind/body, alternative, complementary, or integrative) medicine into everyday care. Quality Letter for Healthcare Leaders. 13(2):2-11, 1, 2001 Feb. 2488. Anonymous. St. John's Wort for wintertime blues. Pennsylvania Medicine. 104(1):22, 2001 Winter. 2489. Anonymous. Alternative medicine. What works...maybe. Harvard Health Letter. 26(3):1-2, 2001 Jan. 2490. Anonymous. Incorporating new (mind/body, alternative, complementary, or integrative) medicine into everyday care. Quality Letter for Healthcare Leaders. 13(2):2-11, 1, 2001 Feb. 2491. Arguedas MR. Fallon MB. Prevention in liver disease. [Review] [38 refs] American Journal of the Medical Sciences. 321(2):145-51, 2001 Feb. 2492. Ascher W. More on BMA's approval of acupuncture. BMA replies to correspondence. BMJ. 322(7277):45, 2001 Jan 6. 2493. Asres K. Bucar F. Kartnig T. Witvrouw M. Pannecouque C. De Clercq E. Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants. Phytotherapy Research. 15(1):62-9, 2001 Feb. 2494. Barone GW. Gurley BJ. Ketel BL. Abul-Ezz SR. Herbal supplements: a potential for drug interactions in transplant recipients. Transplantation. 71(2):239-41, 2001 Jan 27. 2495. Bausell RB. Lee WL. Berman BM. Demographic and health-related correlates to visits to complementary and alternative medical providers. Medical Care. 39(2):190-6, 2001 Feb. 2496. Benford MS. The illusion of nonlocality. Alternative Therapies in Health & Medicine. 7(2):20, 22, 2001 Mar. 2497. Berk LS. Felten DL. Tan SA. Bittman BB. Westengard J. Modulation of neuroimmune parameters during the eustress of humor-associated mirthful laughter. Alternative Therapies in Health & Medicine. 7(2):62-72, 74-6, 2001 Mar. 2498. Berman BM. Complementary medicine and medical education. [letter; comment]. BMJ. 322(7279):121-2, 2001 Jan 20. 2499. Beyerstein BL. Alternative medicine and common errors of reasoning. [Review] [60 refs] Academic Medicine. 76(3):230-7, 2001 Mar. 2500. Boutouyrie P. Corvisier R. Azizi M. Lemoine D. Laloux B. Hallouin M. Laurent S. Effects of acupuncture on radial artery hemodynamics: controlled trials in sensitized and naive subjects. American Journal of Physiology - Heart & Circulatory Physiology. 280(2):H628-33, 2001 Feb. 2501. Bowen B. Distinguishing science from scientists, round two. Alternative Therapies in Health & Medicine. 7(2):17-8, 20, 2001 Mar. 2502. Box S. Creswell B. Hagan DW. Alternative health care education in dietetic training programs: a survey of perceived needs. Journal of the American Dietetic Association. 101(1):108-10, 2001 Jan. 2503. Brown HM. Homoeopathy versus placebo in perennial allergic rhinitis. Did patients really have allergic rhinitis?. BMJ. 322(7279):170-1, 2001 Jan 20. 2504. Caspi O. Integrated medicine: orthodox meets alternative. Bringing complementary and alternative medicine (CAM) into mainstream is not integration. BMJ. 322(7279):168, 2001 Jan 20. 2505. Chow RD. Benign prostatic hyperplasia. Patient evaluation and relief of obstructive symptoms. Geriatrics. 56(3):33-8, 2001 Mar. 2506. Clarke R. Holistic vets must prove their treatments. Australian Veterinary Journal. 79(3):162-3, 2001 Mar. 2507. Cooper RA. Health care workforce for the twenty-first century: the impact of nonphysician clinicians. [Review] [32 refs] Annual Review of Medicine. 52:51-61, 2001. 2508. Cummings M. More on BMA's approval of acupuncture. Acupuncture techniques should be tested logically and methodically. BMJ. 322(7277):46, 2001 Jan 6. 2509. Dean ME. Homoeopathy versus placebo in perennial allergic rhinitis. Study shows double standards in evaluation of homoeopathy. BMJ. 322(7279):169-70; discussion 170-1, 2001 Jan 20. 2510. Deivanayagam CN. Krishnarajasekhar OR. Ravichandran N. Evaluation of Siddha medicare in HIV disease. Journal of the Association of Physicians of India. 49:390-1, 2001 Mar. 2511. Demangeat JL. Poitevin B. Nuclear magnetic resonance: let's consolidate the ground before getting excited! [letter; comment]. British Homoeopathic Journal. 90(1):2-4, 2001 Jan. 2512. Dhar HL. Vasanti T. Endogenous depression, thyroid function and acupuncture. Indian Journal of Physiology & Pharmacology. 45(1):125-6, 2001 Jan. 2513. Dossey L. The nag factor. Alternative Therapies in Health & Medicine. 7(1):12-6, 90-1, 2001 Jan. 2514. Eden JA. Herbal medicines for menopause: do they work and are they safe? [letter; comment]. Medical Journal of Australia. 174(2):63-4, 2001 Jan 15. 2515. Eichler HG. Evidence based medicine, RCTs and their natural enemies: the clinical pharmacologist's role. International Journal of Clinical Pharmacology & Therapeutics. 39(1):1-3, 2001 Jan. 2516. Ernst E. A primer of complementary and alternative medicine commonly used by cancer patients. [Review] [54 refs] Medical Journal of Australia. 174(2):88-92, 2001 Jan 15. 2517. Ernst E. The Lords' report on complementary/alternative medicine: something for everyone. Journal of the Royal Society of Medicine. 94(2):55-6, 2001 Feb. 2518. Ernst E. A primer of complementary and alternative medicine commonly used by cancer patients. [Review] [54 refs] Medical Journal of Australia. 174(2):88-92, 2001 Jan 15. 2519. Fayeton S. van Wassenhoven M. Working Group 'Clinical Verification of Symptoms,' European Committee for Homeopathy. Clinical verification of symptom pictures of homeopathic medicines. British Homoeopathic Journal. 90(1):29-32, 2001 Jan. 2520. Frank E. Methodological issues in trials of acupuncture. JAMA. 285(8):1016, 2001 Feb 28. 2521. Frenkel M. Arye EB. The growing need to teach about complementary and alternative medicine: questions and challenges. [Review] [20 refs] Academic Medicine. 76(3):251-4, 2001 Mar. 2522. Friedman Y. Navigating the world of alternative medicine. Worthwhile Web sites. American Journal of Nursing. 101(3):87-9, 2001 Mar. 2523. Gloth FM 3rd. Pain management in older adults: prevention and treatment. [Review] [93 refs] Journal of the American Geriatrics Society. 49(2):188-99, 2001 Feb. 2524. Gordon D. Billing for alternative services: who gets paid for what, and how?. Managed Care. 10(2):32-4, 2001 Feb. 2525. Gordon JS. The future of complementary and alternative medicine. Quality Letter for Healthcare Leaders. 13(2):12-4, 2001 Feb. 2526. Gordon JS. The White House commission in Washington, DC, and Washington State. Alternative Therapies in Health & Medicine. 7(1):24-6, 28, 2001 Jan. 2527. Grollman AP. Alternative medicine: the importance of evidence in medicine and in medical education. Is there wheat among the chaff?. [Review] [16 refs] Academic Medicine. 76(3):221-3, 2001 Mar. 2528. Gupta R. Singhal S. Goyle A. Sharma VN. Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial. Journal of the Association of Physicians of India. 49:231-5, 2001 Feb. 2529. Haley RW. Fischer RP. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine. 80(2):134-51, 2001 Mar. 2530. Halstead LS. The John Stanley Coulter lecture. The power of compassion and caring in rehabilitation healing. Archives of Physical Medicine & Rehabilitation. 82(2):149-54, 2001 Feb. 2531. Hardy ML. Research in Ayurveda: where do we go from here?. Alternative Therapies in Health & Medicine. 7(2):34-5, 2001 Mar. 2532. Harmsworth K. Lewith GT. Attitudes to traditional Chinese medicine amongst Western trained doctors in the People's Republic of China. Social Science & Medicine. 52(1):149-53, 2001 Jan. 2533. Hoffer LJ. Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies. [see comments]. CMAJ. 164(3):351-3, 2001 Feb 6. 2534. Jacobs FN. Complementary medicine: a case study. Healthcare Executive. 16(1):56-7, 2001 Jan-Feb. 2535. Johansson BB. Haker E. von Arbin M. Britton M. Langstrom G. Terent A. Ursing D. Asplund K. Swedish Collaboration on Sensory Stimulation After Stroke. Acupuncture and transcutaneous nerve stimulation in stroke rehabilitation: a randomized, controlled trial. Stroke. 32(3):707-13, 2001 Mar. 2536. Kaur S. Grover IS. Kumar S. Antimutagenic potential of extracts isolated from Terminalia arjuna. Journal of Environmental Pathology, Toxicology & Oncology. 20(1):9-14, 2001. 2537. Kawada A. Aragane Y. Shiraishi H. Tezuka T. Fixed drug eruption due to scopolia extract. Contact Dermatitis. 44(2):101, 2001 Feb. 2538. Kaye AD. Heavner JE. Sabar R. Nutraceuticals and risk of neuraxial bleeding. Regional Anesthesia & Pain Medicine. 26(1):92-3, 2001 Jan-Feb. 2539. Kemper KJ. Complementary and alternative medicine for children: does it work?. [Review] [60 refs] Archives of Disease in Childhood. 84(1):6-9, 2001 Jan. 2540. Kessler RC. Soukup J. Davis RB. Foster DF. Wilkey SA. Van Rompay MI MI. Eisenberg DM. The use of complementary and alternative therapies to treat anxiety and depression in the United States. American Journal of Psychiatry. 158(2):289-94, 2001 Feb. 2541. Knight B. Mudge C. Openshaw S. White A. Hart A. Effect of acupuncture on nausea of pregnancy: a randomized, controlled trial. Obstetrics & Gynecology. 97(2):184-8, 2001 Feb. 2542. Koga K. Shigematsu A. Noguchi T. Shiga Y. Should epidurals be avoided in acupunctured patients?. Anaesthesia. 56(3):291-2, 2001 Mar. 2543. Lampert N. Complementary and alternative medicine. Lancet. 357(9258):802, 2001 Mar 10. 2544. Larwood B. Is it all black magic?. Australian Family Physician. 30(3):202, 2001 Mar. 2545. Laskin DM. Taking the wrong alternatives. Journal of Oral & Maxillofacial Surgery. 59(1):1, 2001 Jan. 2546. Levin J. Steele L. On the epidemiology of 'mysterious' phenomena. Alternative Therapies in Health & Medicine. 7(1):64-6, 2001 Jan. 2547. Lipworth BJ. Homoeopathy versus placebo in perennial allergic rhinitis. Study shows dissociation between objective and subjective responses to homoeopathy in allergic rhinitis. BMJ. 322(7279):169; discussion 170-1, 2001 Jan 20. 2548. Long L. Ernst E. Homeopathic remedies for the treatment of osteoarthritis: a systematic review. [Review] [45 refs] British Homoeopathic Journal. 90(1):37-43, 2001 Jan. 2549. Mackey P. Complementary therapies. Medical Journal of Australia. 174(2):105-7, 2001 Jan 15. 2550. Mahady GB. Global harmonization of herbal health claims. [Review] [15 refs] Journal of Nutrition. 131(3s):1120S-3S, 2001 Mar. 2551. Manjunatha S. Jaryal AK. Bijlani RL. Sachdeva U. Gupta SK. Effect of Chyawanprash and vitamin C on glucose tolerance and lipoprotein profile. Indian Journal of Physiology & Pharmacology. 45(1):71-9, 2001 Jan. 2552. Marcus DM. How should alternative medicine be taught to medical students and physicians?. [Review] [69 refs] Academic Medicine. 76(3):224-9, 2001 Mar. 2553. McQueen CE. Bryant PJ. Pygeum. [Review] [31 refs] American Journal of Health-System Pharmacy. 58(2):120-3, 2001 Jan 15. 2554. Meenan R. Developing appropriate measures of the benefits of complementary and alternative medicine. [Review] [32 refs] Journal of Health Services & Research Policy. 6(1):38-43, 2001 Jan. 2555. Meidan VM. Touitou E. Treatments for androgenetic alopecia and alopecia areata: current options and future prospects. [Review] [95 refs] Drugs. 61(1):53-69, 2001. 2556. Milgrom LR. King KR. Lee J. Pinkus AS. On the investigation of homeopathic potencies using low resolution NMR T2 relaxation times: an experimental and critical survey of the work of Roland Conte et al. [see comments]. British Homoeopathic Journal. 90(1):5-13, 2001 Jan. 2557. Miller B. Homoeopathy versus placebo in perennial allergic rhinitis. Statistics in study were flawed. BMJ. 322(7279):169; discussion 170-1, 2001 Jan 20. 2558. Mills SY. Regulation in complementary and alternative medicine. BMJ. 322(7279):158-60, 2001 Jan 20. 2559. Mishra L. Singh BB. Dagenais S. Ayurveda: a historical perspective and principles of the traditional healthcare system in India. Alternative Therapies in Health & Medicine. 7(2):36-42, 2001 Mar. 2560. Mishra L. Singh BB. Dagenais S. Healthcare and disease management in Ayurveda. [Review] [28 refs] Alternative Therapies in Health & Medicine. 7(2):44-50, 2001 Mar. 2561. Mishra L. Status of ayurvedic education and licensing in the United States. Alternative Therapies in Health & Medicine. 7(1):20, 2001 Jan. 2562. Morrell P. Integrated medicine: orthodox meets alternative. Integrated medicine is not new. BMJ. 322(7279):168-9, 2001 Jan 20. 2563. Moss RW. Complementary and alternative medicine. Lancet. 357(9258):803, 2001 Mar 10. 2564. Muscat M. Dolphinswim: finding your 'first self' in the deep blue sea. Alternative Therapies in Health & Medicine. 7(2):98-9, 2001 Mar. 2565. Muscat M. Straus gives state of the center, CAM on PUBMED unveiled. Alternative Therapies in Health & Medicine. 7(2):23-6, 2001 Mar. 2566. Nahin RL. Straus SE. Research into complementary and alternative medicine: problems and potential. BMJ. 322(7279):161-4, 2001 Jan 20. 2567. Owen D. Lewith GT. Complementary and alternative medicine (CAM) in the undergraduate medical curriculum: the Southampton experience. Medical Education. 35(1):73-7, 2001 Jan. 2568. Owen DK. Lewith G. Stephens CR. Can doctors respond to patients' increasing interest in complementary and alternative medicine? [see comments]. BMJ. 322(7279):154-8, 2001 Jan 20. 2569. Park J. White AR. Ernst E. New sham method in auricular acupuncture. Archives of Internal Medicine. 161(6):894; discussion 895, 2001 Mar 26. 2570. Phillips KD. Skelton WD. Effects of individualized acupuncture on sleep quality in HIV disease. Journal of the Association of Nurses in AIDS Care. 12(1):27-39, 2001 Jan-Feb. 2571. Pinn G. The herbal basis of some gastroenterology therapies. Australian Family Physician. 30(3):254-8, 2001 Mar. 2572. Rahman K. Historical perspective on garlic and cardiovascular disease. [Review] [29 refs] Journal of Nutrition. 131(3s):977S-9S, 2001 Mar. 2573. Rajbhandari M. Wegner U. Julich M. Schopke T. Mentel R. Screening of Nepalese medicinal plants for antiviral activity. Journal of Ethnopharmacology. 74(3):251-5, 2001 Mar 3. 2574. Roth T. Hajak G. Ustun TB. Consensus for the pharmacological management of insomnia in the new millennium. [116 refs] International Journal of Clinical Practice. 55(1):42-52, 2001 Jan-Feb. 2575. Saary MJ. Holness DL. Contact dermatitis from white flower embrocation. Contact Dermatitis. 44(2):100, 2001 Feb. 2576. Sampson W. The need for educational reform in teaching about alternative therapies. Academic Medicine. 76(3):248-50, 2001 Mar. 2577. Sharma P. Sharma JD. A review of plant species assessed in vitro for antiamoebic activity or both antiamoebic and antiplasmodial properties. [Review] [60 refs] Phytotherapy Research. 15(1):1-17, 2001 Feb. 2578. Siegel B. Nonlocal consciousness observed firsthand. Alternative Therapies in Health & Medicine. 7(1):17, 2001 Jan. 2579. Singer AJ. Alternative medicine-why should we care?. [Review] [19 refs] Academic Emergency Medicine. 8(1):65-7, 2001 Jan. 2580. Singh BB. Mishra L. Aquilina N. Kohlbeck F. Usefulness of guggul (Commiphora mukul) for osteoarthritis of the knee: An experimental case study. Alternative Therapies in Health & Medicine. 7(2):120, 112-4, 2001 Mar. 2581. Soejarto DD. Intellectual property rights and indigenous knowledge: credit where credit is due. Journal of Ethnopharmacology. 74(3):iii, 2001 Mar 3. 2582. Spake A. Natural hazards. Tonic or toxic? Americans are gobbling up nature's remedies for everything from obesity to depression. US News & World Report. 130(6):42-9, 2001 Feb 12. 2583. Srinivasan D. Nathan S. Suresh T. Lakshmana Perumalsamy P. Antimicrobial activity of certain Indian medicinal plants used in folkloric medicine. Journal of Ethnopharmacology. 74(3):217-20, 2001 Mar 3. 2584. Stam C. Bonnet MS. van Haselen RA. The efficacy and safety of a homeopathic gel in the treatment of acute low back pain: a multi-centre, randomised, double-blind comparative clinical trial. British Homoeopathic Journal. 90(1):21-8, 2001 Jan. 2585. Steyer TE. Complementary and alternative medicine: a primer. [Review] [9 refs] Family Practice Management. 8(3):37-42, 2001 Mar. 2586. Suarez-Almazor ME. Kendall CJ. Dorgan M. Surfing the Net--information on the World Wide Web for persons with arthritis: patient empowerment or patient deceit? [see comments]. Journal of Rheumatology. 28(1):185-91, 2001 Jan. 2587. Tagliaferri M. Cohen I. Tripathy D. Complementary and alternative medicine in early-stage breast cancer. [Review] [108 refs] Seminars in Oncology. 28(1):121-34, 2001 Feb. 2588. Talalay P. Talalay P. The importance of using scientific principles in the development of medicinal agents from plants. [Review] [41 refs] Academic Medicine. 76(3):238-47, 2001 Mar. 2589. Walker AF. Middleton RW. Petrowicz O. Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post-marketing surveillance study. Phytotherapy Research. 15(1):58-61, 2001 Feb. 2590. Wang SM. Kain ZN. Auricular acupuncture: a potential treatment for anxiety. Anesthesia & Analgesia. 92(2):548-53, 2001 Feb. 2591. Weiss SJ. Takakuwa KM. Ernst AA. Use, understanding, and beliefs about complementary and alternative medicines among emergency department patients. Academic Emergency Medicine. 8(1):41-7, 2001 Jan. 2592. Windeler J. Homoeopathy versus placebo in perennial allergic rhinitis. Results of study were not convincingly in favour of homoeopathy. BMJ. 322(7279):170; discussion 170-1, 2001 Jan 20. 2593. Xu HX. Lee SF. Activity of plant flavonoids against antibiotic-resistant bacteria. Phytotherapy Research. 15(1):39-43, 2001 Feb.
|